Vorinostat (SAHA, MK0683)

Catalog No.S1047

Vorinostat (suberoylanilide hydroxamic acid, SAHA) is an HDAC inhibitor with IC50 of ~10 nM in a cell-free assay.

Price Stock Quantity  
USD 191 In stock
USD 147 In stock
USD 220 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Vorinostat (SAHA, MK0683) Chemical Structure

Vorinostat (SAHA, MK0683) Chemical Structure
Molecular Weight: 264.3

Validation & Quality Control

Cited by 99 publications:

20 customer reviews :

Quality Control & MSDS

Related Compound Libraries

HDAC Inhibitors with Unique Features

Product Information

  • Compare HDAC Inhibitors
    Compare HDAC Products
  • Research Area
  • Vorinostat (SAHA, MK0683) Mechanism
  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description Vorinostat (suberoylanilide hydroxamic acid, SAHA) is an HDAC inhibitor with IC50 of ~10 nM in a cell-free assay.
Targets HDAC [1]
(Cell-free assay)
IC50 ~10 nM
In vitro Vorinostat inhibits the activities of HDAC1 and HDAC3 with IC50 of 10 nM and 20 nM, respectively. Vorinostat also results in a marked hyperacetylation of histone H4. [1] Vorinostat inhibits the growth of three prostate cancer cell lines LNCaP, PC-3 and TSU-Pr1 at micromolar concentrations (2.5-7.5 μM), and induces dose-dependent cell death in LNCaP cells. [2] Vorinostat treatment in MCF-7 cells inhibits cell proliferation at an IC50 of 0.75 μM resulting in the accumulation of cells in the G1 and G2-M phase of the cell cycle. Vorinostat also induces differentiation in the estrogen receptor-negative cell line SKBr-3 and the retinoblastoma-negative cell line MDA-468. [3] Vorinostat treatment at 1 μM for 8 hours or more is sufficient to irreversibly induce apoptosis of human multiple myeloma (MM) cells. The gene expression profiles of Vorinostat treated MM cells are not hallmarked by global transcriptional activation, but by coordinated transcriptional changes of specific functional groups of genes such as cytokine-induced proliferative/survival signaling cascades, oncogenes-tumor suppressor genes, regulators of apoptosis, DNA synthesis-repair and cell cycle, and proteasome-ubiquitin function. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
A20NVnQc3Z5U2mwYYPlJGF{e2G7NX2wVlhkOSCqNVT3dmc5TE2VTx?=MoDsZY51cS2KRFHDNUBi[3Srdnn0fUB4cXSqIFnDOVAhd2ZiMD6xNVIh|ryPMoHmNVE6PjB2OEm=
Friend leukemic cellMoLzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2H0OlUxKM7:TR?=Ml\VO|IhcA>?M2XYOGROW09?NHPLfFdKSzVyPUCuPVkh|ryPMlLkNVIyODl7MUO=
K562Ml\ST4lv[XOnIFHzd4F6M3;iOVYhcA>?Mm\qSG1UVw>?M1r6XGlvcGmkaYTpc44hd2ZiaIXtZY4hcGm|dH;u[UBl\WGlZYT5cIF{\SBqbXn4eJVz\SCxZjDISGFEOSCjbnSgTGRCSzJrIIfpeIghUUN3MDDv[kAxNjBzIN88US=>NYq4Z3JUOTJ2MUmzPFA>
HT1080NYDQepJmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnHFO|IhcA>?M{PkeGROW09?Ml\JTWM2OD1{LkSg{txOM3LLR|EzOjdyMUe1
H1299MVTLbY5ie2ViQYPzZZk>NGTqTIczOCCvaX6=NFfNNIdFVVORMoC0TY5pcWKrdH;yfUBi[3Srdnn0fUBi\2GrboP0JGhFSUNiZX76fY1mKHerdHigTWM2OCCxZjCwMlE6PCEQvF2=MkDZNVQ2OjF2MkK=
H1299MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYe3NkBpNXjSenB5TE2VTx?=M3;tUmlEPTB;Nz6yOEDPxE1?NEX4RWgyPDV{MUSyNi=>
HeLaMWrLbY5ie2ViQYPzZZk>NIC5U4E{OCCvaX6=MXXJcohq[mm2b4L5JINwdmOnboTyZZRqd25iYXfhbY5{fCCqaYP0c45mKGSnYXPleJlt[XOnIIfpeIghUUN3MDDv[kAxNjJ6IN88US=>MVKxOVYxOzl2OR?=
LOX-IMVIMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVXhfJVbPDhiaB?=MXTJR|UxRTFwMzFOwG0>M3;GOVE2PzF3NEew
NCI-H226MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLIOFghcA>?NEXsfnlKSzVyPUKuOkDPxE1?MX6xOVcyPTR5MB?=
RXF-631LMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGP0eo81QCCqMVTJR|UxRTJizszNNG\YXmMyPTdzNUS3NC=>
SNB-78NYTmWYp4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIjXOFU1QCCqNVjDZnAyUUN3ME2xOkDPxE1?NUXEcGMxOTV5MUW0O|A>
St-4NWHCXZpVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVG0PEBpNUjqSJJDUUN3ME21MlIh|ryPM{PyflE2PzF3NEew
ARP1MkTuSpVv[3Srb36gRZN{[Xl?MXiyJO69VQ>?NFrWclk3KGh?M{SzfWlv\HWldHnvckBw\iCSMkHXRWYyKGenbnWg[ZhxemW|c3nvci=>NYrzTGs{OTR5M{S4NFY>
CEMM1jrcGtqdmG|ZTDBd5NigQ>?NFHYdlQyKGh?MUDEUXNQNEP3eWVKdmirYnn0bY9vKG:oIFjERWMhf2m2aDDJR|UxKG:oIECuN|Mh|ryPNIW1Sm0yPjR{MEC2OC=>
HCT15M1fPT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NETTXZo1QCCqM2m4ZWdKPTB;MD64NkDPxE1?MV[xOlczOzJ{Nx?=
NCI-H23MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYPPW2Z4PDhiaB?=MmrUS2k2OD1yLkmyJO69VQ>?NY[1cWk5OTZ5MkOyNlc>
GM15850NVvqVoVzU2mwYYPlJGF{e2G7MlzGNk42KM7:TR?=NVTCUIxuQTZiaB?=NUXQZWV4TE2VTx?=NVfHVnB4UW6qaXLpeIlwdiCxZjDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFMhdHm|aX7lJFE1KGGlZYT5cIF1cW:wIH;mJGZZViCpZX7lM4DSNVE3QTJzM{[3
GM15850MnHPT4lv[XOnIFHzd4F6M2DxbFIvPSEQvF2=MXG5OkBpNXTlWXJ5TE2VTx?=MW\Jcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iaHnzeI9v\SCKNDDsfZNqdmViNTDhZ4V1gWyjdHnvckBw\iCIWF6g[4Vv\Q>?MkLZNVY6OjF|Nke=
GM15850M{TMcWtqdmG|ZTDBd5NigQ>?NUnJU5BYOi53IN88US=>MUW5OkBpM2DQeGROW09?NX7vXGJzUW6qaXLpeIlwdiCxZjDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm|aX7lJFEzKGGlZYT5cIF1cW:wIH;mJGZZViCpZX7lMXqxOlkzOTN4Nx?=
GM15850M3\LSGtqdmG|ZTDBd5NigQ>?NFnic20zNjVizszNM1nzWFk3KGh?NELtdGZFVVORMojKTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHjpd5RwdmViSEOgcJl{cW6nIEmgZYNmfHmuYYTpc44hd2ZiRmjOJIdmdmV?NVrVfmlQOTZ7MkGzOlc>
GM15850MYPLbY5ie2ViQYPzZZk>NVXJV3lROi53IN88US=>NWDzR4Y{QTZiaB?=MlvUSG1UVw>?NEPyS2lKdmirYnn0bY9vKG:oIFjERWMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIOEBtgXOrbnWgPEBi[2W2eXzheIlwdiCxZjDGXG4h\2WwZR?=M2TveVE3QTJzM{[3
GM15850NFrWZpVMcW6jc3WgRZN{[Xl?NU[4OZM6Oi53IN88US=>M2m2U|k3KGh?NFXnTXBFVVORMmToTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHjpd5RwdmViSESgcJl{cW6nIEG2JIFk\XS7bHH0bY9vKG:oIF\YUkBo\W6nNV\5OoZiOTZ7MkGzOlc>
U937MXnGeY5kfGmxbjDBd5NigQ>?M3jxRVUh|ryPM3XJVlI1KGh?MVHEUXNQNYWwSGp5S2WubDDjfYNt\SCjcoLld5Qh[nliYXPjeY12dGG2aX;uJIF1KFNxR{KvUUBxcGG|ZR?=MVWxO|AxPDdzOB?=
H661M{i5PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4rpTVQ5KGh?NHyxXW5KSzVyPUGg{txONXHZWo9qOTdzNUewNFk>
U937NETDc4pHfW6ldHnvckBCe3OjeR?=NH\lOpA2KM7:TR?=NGPBbIczPCCqNVqzVGp7TE2VTx?=MVLJcoNz\WG|ZTDpckBpcXO2b37lJGg{KGGlZYT5cIF1cW:wM{XjTlE4PDR5N{Ww
U937Mnq0SpVv[3Srb36gRZN{[Xl?NXXUZm5vOSEQvF2=NXS2eIJnOjRiaB?=M1HsPGROW09?NETuWIVG\m[nY4Sgc44h[WyyaHGgeJVjfWyrbjDhZ4V1gWyjdHnvci=>MVqxO|Q1Pzd3MB?=
RAW264.7M3j3dmZ2dmO2aX;uJGF{e2G7M1XmU|ExKM7:TR?=M2XYdlI1cA>?NYj6TlJlf2G2ZYK=MYHJcohq[mm2aX;uJI9nKEySUz3zeIlufWyjdHXkJHRPTmGucHjhJJBzd2S3Y4Tpc44hf2m2aDDJR|UxKG:oIECuO|Yh|ryPNUT2bFREOTd2N{e1NVg>
RAW264.7MWDGeY5kfGmxbjDBd5NigQ>?MWKxNEDPxE1?MVOyOIg>Mlzpe4F1\XJ?MUTJcohq[mm2aX;uJI9nKEySUz3zeIlufWyjdHXkJG5QKHC{b3T1Z5Rqd25id3n0bEBKSzVyIH;mJFEvQDhizszNNVTTbG1YOTd2N{e1NVg>
SC9MnniS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHXTcnM1QCCqMnfXTWM2OD1yLk[wOkDPxE1?MVOxO|UxPzJzOR?=
ST14AMVnGeY5kfGmxbjDBd5NigQ>?M3fiV|Uhdk1?NUPXNnVWPzJiaB?=NUXERoY3UW6lcnXhd4UhcW5iUlXTWE9PWlOIIH3SUmEh\XiycnXzd4lwdg>?MX[xO|U3PTl7Mx?=
ST14AMofOSpVv[3Srb36gRZN{[Xl?NX7pN25qPSCwTR?=NEniTWs4OiCqM{DDeGlv[3KnYYPlJIlvKEV{RkGgcXJPSSCneIDy[ZN{cW:wNX[4WplWOTd3NkW5PVM>
PANC1M3rEWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1fiN|Eh|ryPNGjOZWhKSzVyPUCuOFUh|ryPM2faelE4PTh6N{S0
PANC1MorDSpVv[3Srb36gRZN{[Xl?MVKxJO69VQ>?NXnGXGI4OjRiaB?=NWqx[opHUW6lcnXhd4UhcW5icEKxW2FHOS:FSWCxJIdmdmViZYjwdoV{e2mxbh?=MkHSNVc2QDh5NES=
PANC1M3vOOWZ2dmO2aX;uJGF{e2G7MoTENUDPxE1?MkmxNlQhcA>?NXuzdVlUUW6lcnXhd4UhcW5icEK3b4lxOSCpZX7lJIV5eHKnc4Ppc44>NE\FRpoyPzV6OEe0OC=>
PT45M2fMdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4PZbGlEPTB;NDFOwG0>M4fSW|E4PTh6N{S0
ACHNNH7S[YtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGLTSJozOSCqMmfIS2k2OD1yLk[1JO69VQ>?Mn\jNVc3PjJ4ME[=
PC3NU\aSnpRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MU[yNUBpNGL4N4VIUTVyPUCuO|Eh|ryPMlfaNVc3PjJ4ME[=
A431M3TCcWN6fG:2b4jpZ{BCe3OjeR?=MorsO|IhcA>?Mkm2TWM2OD12LkKg{txOMkL1NVc3QTF5NkO=
Cal27MmTLR5l1d3SxeHnjJGF{e2G7NET1cZA4OiCqNV\ZdWRIUUN3ME2zMlIh|ryPMmPmNVc3QTF5NkO=
CCRF-CEMNGjJdYNEgXSxdH;4bYMhSXO|YYm=MV:3NkBpNH7yfVdKSzVyPUCuPEDPxE1?NHnQTlUyPzZ7MUe2Ny=>
EOL1NGnvfpBEgXSxdH;4bYMhSXO|YYm=M2LiPFczKGh?Mn:wTWM2OD1zIN88US=>NGnPXYYyPzZ7MUe2Ny=>
Hec-1-AMoDxR5l1d3SxeHnjJGF{e2G7MV[3NkBpNF7FWZFKSzVyPUGg{txONF2zO|IyPzZ7MUe2Ny=>
HeLaM4jNWGtqdmG|ZTDBd5NigQ>?NF7TXHcyOCEQvF2=NHr5TYc{OCCvaX6=MVnEUXNQM33jUGlvcGmkaYTpc44hd2ZicnXjc41jcW6jboSgTGRCSzFid3n0bEBKSzVyIH;mJFAvODJizszNNITSNnAyPzZ7MUe2Ny=>
RKOp21NWfadmpiS3m2b4TvfIlkKEG|c3H5MUe3NkBpM4DwSmlEPTB;MT63OkDPxE1?M3Hm[VE4PjlzN{[z
Saos2M{S3T2N6fG:2b4jpZ{BCe3OjeR?=MWe3NkBpNUL1NYdsUUN3ME2yMlMh|ryPNWfSdoVxOTd4OUG3OlM>
SK-OV-3MmfHR5l1d3SxeHnjJGF{e2G7NFL2Vm44OiCqNGfiXZJKSzVyPUKuNkDPxE1?NIHOeZQyPzZ7MUe2Ny=>
U87MGMXvDfZRwfG:6aXOgRZN{[Xl?MVG3NkBpNH:wTYtKSzVyPUGxJO69VQ>?MWixO|Y6OTd4Mx?=
NUGC3NGXGOmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWPmT4RGPSEQvF2=Mn7ONlQhcA>?NYDRSo9iT0l3ME2yMlc6KM7:TR?=MlS4NVc6ODR6NEO=
CCD1059SKNXToTHh1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1PSS2lEPTB;NEOuOUDPxE1?MYGxPFI1PzV3NB?=
HepG2MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUDHOmpTUUN3ME2wMlAxODZizszNMV2xPFI1PzV3NB?=
HT1080MkT3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWqwPIxNUUN3ME2wMlAxOjRizszNNYjtXXFzOTh{NEe1OVQ>
SKBR3M{HadWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVznOGJ2UUN3ME2wMlgh|ryPNYLKb2d5OTh{NEe1OVQ>
SNB78NYfaTlJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYnwT3p5TUN3ME2xOkDPxE1?M4LTPFE5OjR5NUW0
SQ20BMlvsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVvXOoFYUUN3ME2zJO69VQ>?NUT2TI1NOTh{NEe1OVQ>
St4M2ezS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXnUOGp1TUN3ME21MlIh|ryPMl3INVgzPDd3NUS=
MCF7MoPaSpVv[3Srb36gRZN{[Xl?NUjWcm41OTBizszNNEPJO4c5KGh?MlW3SG1UVw>?NGfQcGNKdmS3Y4Tpc44hd2ZidIXieYxqdiCqeYDldoFk\XS7bHH0bY9vNUWxendUOTh{NkmyNlY>
HEK293MXnLbY5ie2ViQYPzZZk>MXixJIg>Ml2wSG1UVw>?MV\Jcohq[mm2aX;uJI9nKEiGQVOxJJdqfGhiSVO1NEBw\iByLkCzJO69VQ>?NH[xZoMyQDNyOEW2Ny=>
HEK293NHLh[otMcW6jc3WgRZN{[Xl?MkG1NUBpNYDZO2xwTE2VTx?=M{OwbGlvcGmkaYTpc44hd2ZiSFTBR|Mhf2m2aDDJR|UxKG:oIECuNFU4KM7:TR?=M3rLNFE5OzB6NU[z
G401M3qyNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3rONFczKGh?M2Dmc2ROW09?NVPSfJU2UUN3ME2xJO69VQ>?MWexPFM4ODN5Mx?=
HeLaNYTEemEzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{PIdVczKGh?MX;EUXNQM2nUUGlEPTB;MD60OkDPxE1?NX\vUWlIOTh|N{CzO|M>
Human renal epithelial cellNF25N3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mof0O|IhcA>?M3:2TGROW09?MXfJR|UxRTF2IN88US=>MoTRNVg{PzB|N{O=
U937M3rRWGZ2dmO2aX;uJGF{e2G7M3jENlUh|ryPNV:ycndwOjRiaB?=NH7kZYJKdmS3Y4Tpc44hd2ZiaHnzeI9v\SCKNDDofZBmemGlZYT5cIF1cW:wMV[xPFM5OTJ|OB?=
U937NYn4WYlHTnWwY4Tpc44hSXO|YYm=MXy1JO69VQ>?MnPPNlQhcA>?M4ewNGlv\HWldHnvckBw\iCjbIDoZUB1fWK3bHnuJIh6eGW{YXPleJlt[XSrb36=NIX4d3cyQDN6MUKzPC=>
U937NYW4dpg5TnWwY4Tpc44hSXO|YYm=NWT6PGVNPSEQvF2=NI\HdnAzPCCqMXnJcoR2[3Srb36gc4YheDJzIHX4dJJme3Orb36=NVXwW2xzOTh|OEGyN|g>
U937NYTRdWhlTnWwY4Tpc44hSXO|YYm=MkXFOUDPxE1?M{TSVFI1KGh?MlrUTY5lfWO2aX;uJI9nKGGyb4D0c5Nqew>?NH;1cHAyQDN6MUKzPC=>
U937MnvVSpVv[3Srb36gRZN{[Xl?MonhOUDPxE1?Mny1NlQhcA>?M3jUfGlv\HWldHnvckBw\iCpcnHueYxw[3m2aXOg[Iln\mW{ZX70bYF1cW:wNFTMSVUyQDN6MUKzPC=>
U937NX3uUWljU2mwYYPlJGF{e2G7NGLzZVY2KM7:TR?=MoP0NlQhcA>?MmXJTY5pcWKrdHnvckBw\iCqdX3hckBJTEGFMR?=M4OxfFE5OzhzMkO4
U937MWrLbY5ie2ViQYPzZZk>NVX3Zm5{PSEQvF2=MorxNlQhcA>?M1nLNWlvcGmkaYTpc44hd2ZiaIXtZY4hUESDQ{S=NELSNFQyQDN6MUKzPC=>
HEK-TENFH3UphHfW6ldHnvckBCe3OjeR?=NEHtfoE2KM7:TR?=NXTYdGxtPmh?NVnuZ4x[TE2VTx?=MV3JcoNz\WG|ZTDpckBpcXO2b37lJGg{KGGlZYT5cIF1cW:wNHLjVmcyQDR|NEG0OC=>
HPDE6c7NX[yS2FuS3m2b4TvfIlkKEG|c3H5NYTVO5JsPTBizszNM3;0dVczKGh?M1PTZmROW09?M3zFRmlEPTB;MT6zJO69VQ>?M2rHZlE5PDl2NE[z
Human microvascular epithelial cellNYSwNZRCS3m2b4TvfIlkKEG|c3H5MWK1NEDPxE1?NHTEV4Y4OiCqM{PwWGROW09?M1zBXmlEPTB;MT6zJO69VQ>?NYrEb4czOTh2OUS0OlM>
Hup T3MWLDfZRwfG:6aXOgRZN{[Xl?NVTN[5VGPTBizszNNGDrV3o4Omh?MnfWSG1UVw>?NFnj[nhKSzVyPUCuPEDPxE1?NXWxcJVjOTh2OUS0OlM>
Mia Paca2MY\DfZRwfG:6aXOgRZN{[Xl?M4Pi[FUxKM7:TR?=M37uWlczcA>?NULMO3llTE2VTx?=MkHITWM2OD1zLkGg{txOMkHFNVg1QTR2NkO=
Panc 04.03M3WwZWN6fG:2b4jpZ{BCe3OjeR?=MnvoOVAh|ryPMVe3Nog>Mmn0SG1UVw>?NGniWItKSzVyPUGuNkDPxE1?NFrUNZUyQDR7NES2Ny=>
SU 86.86NG\QVXZEgXSxdH;4bYMhSXO|YYm=M3\tNlUxKM7:TR?=MoS3O|JpMXHEUXNQNVrD[I5rUUN3ME2xMlMh|ryPNV7ReYsxOTh2OUS0OlM>
HEK293MorWT4lv[XOnIFHzd4F6MUSzJIg>MXrJcohq[mm2aX;uJI9nKHKnY3;tZolv[W62IFjERWM3KGW6cILld5Nqd25id3n0bEBKSzVyIH;mJFAvODF7IN88US=>NF36bWoyQDV3OE[2PS=>
HeLaNEiyXnVMcW6jc3WgRZN{[Xl?MnT5NkBpNUXHVII2UW6qaXLpeIlwdiCxZjDueYNt\WG{IFjERWMhf2m2aDDJR|UxKG:oIECuNFg{KM7:TR?=NHnP[JMyQDV3OE[2PS=>
RAW264.7NUP5SGlETnWwY4Tpc44hSXO|YYm=NXv3U2hoOiEQvF2=M2CzRVMvPSCqM4njUWROW09?Mo[xRY51cW2jbHHybYFtKGGldHn2bZR6KGGpYXnud5QhWGyjc33v[Il2dSCoYXzjbZBienWvIHnu[oVkfGWmIIfpeIghUUN3MDDv[kAxNjFzIN88US=>NGqxVJQyQDZ2NEm2PS=>
NB4MoD2OFhpMn;NSG1UVw>?NFe2e21KSzVyPUCuOkDPxE1?MWOxPFczOzN2OR?=
HEK293MU\GeY5kfGmxbjDBd5NigQ>?MVmxNEDPxE1?MlPaNlQhcA>?NWe3T2RTTE2VTx?=M1vTSmFkfGm4YYTpc44hd2ZibX;1d4UhX262M3Ggd4lodmGuaX7nJIV5eHKnc4Pl[C=>NHPrd4IyQTB{Mk[3OS=>
HCT116MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV[3Nog>NIqwOXhFVVORMUXJR|UxRTBwM{Gg{txONGjzUHAyQTB6NEK5OC=>
HeLaMWXLbY5ie2ViQYPzZZk>NFXvbYUzKM7:TR?=NG\kS5g{OCCvaX6=NVXMZ5UyTE2VTx?=NVLWSnljUW6qaXLpeIlwdiCxZjDISGFEOiCrbjDoeY1idiCKZVzhJINmdGy|IIfpeIghUUN3MDDv[kAxNjFizszNMYWxPVA5PDJ7NB?=
IGROV1NV7EW3RGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkezO|IhcA>?MUPEUXNQM1PrZmlEPTB;Mj6yJO69VQ>?M3;CfVE6ODh2Mkm0
IGROV1NVf3TpBoU2mwYYPlJGF{e2G7MXi1JO69VQ>?NEXhSHEzPCCqMWHEUXNQM3K0TWlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCyNUOgZYNmfHmuYYTpc44>M3zselE6ODh2Mkm0
IGROV1NUHhRlZSU2mwYYPlJGF{e2G7MmfrNVAh|ryPMkjxOEBpM2fLfGROW09?NEjDPVFKdmirYnn0bY9vKG:oIFjERWMh[XO|ZYPz[YQh[XNiaHnzeI9v\S2KNDDhZ4V1gWyjdHnvci=>NXvUW5RuOTlyOESyPVQ>
IGROV1NX\zN2JFU2mwYYPlJGF{e2G7NHTsNWMyOCEQvF2=MX60JIg>MV;EUXNQM{XIUGlvcGmkaYTpc44hd2ZiSFTBR|Yh[XO|ZYPz[YQh[XNiYXzwbIEufHWkdXzpckBi[2W2eXzheIlwdg>?NWDhV41oOTlyOESyPVQ>
T24NHXoVmxMcW6jc3WgRZN{[Xl?Ml;tN{BpMXrJcoR2[3Srb36gc4YhcGm|dH;u[UBJOyCjY3X0fYxifGmxbjD3bZRpKEWFNUCgc4YhOC5zMjFOwG0>NHHJUoUyQTB6NEO5OS=>
T24NHnEeWZMcW6jc3WgRZN{[Xl?M2nWVlMhcA>?MXLJcoR2[3Srb36gc4Yh[WyyaHGgeJVjfWyrbjDhZ4V1gWyjdHnvckB4cXSqIFXDOVAhd2ZiMD6yOUDPxE1?NHHwbGgyQTB6NEO5OS=>
HeLaMWHLbY5ie2ViQYPzZZk>NXLoTldHOTVibXnuMlfhSG1UVw>?MmT5TY5pcWKrdHnvckBw\iCKRFHDOkBnem:vIH71Z4xm[XJiZYj0doFkfCC5aYToJGlEPTBib3[gNE4xQDV3IN88US=>NHHGU5AyQTB7M{i4OC=>
HeLaNYPTUZJ1U2mwYYPlJGF{e2G7Mm[xNVUhdWmwNWDyZollTE2VTx?=NV62bGdvUW6qaXLpeIlwdiCxZjDISGFEQCCocn;tJI52[2ynYYKg[Zh1emGldDD3bZRpKEmFNUCgc4YhOS56NjFOwG0>NYPCeWo{OTlyOUO4PFQ>
NCI-H69MlPCR5l1d3SxeHnjJGF{e2G7M2PIWlczKGh?MoLzSG1UVw>?MVjJR|UxRTJwME[g{txOMYixPVA6Ozh6NB?=
SKMES1MoLMR5l1d3SxeHnjJGF{e2G7NE[0T5M4OiCqNV;CNmdiTE2VTx?=MY\JR|UxRTJwNEKg{txONETIdHQyQTB7M{i4OC=>
S2MkDLT4lv[XOnIFHzd4F6NGP6OpAxNjFvMUCg{txOM3nUclEhcA>?MomwTY5pcWKrdHnvckBw\iCSbHHzcY9lcXWvIH\hcINqeGG{dX2gTGRCSzFiZYjwdoV{e2WmIIfpeIghUUN3MDDv[kAxNjB3OTFOwG0>MkD6NVk{OTd2NUC=
SHSY5YNFy0T29McW6jc3WgRZN{[Xl?NWO3Tm5oOTBizszNNYjPTWx1PDhiaB?=MYTEUXNQM1POe2lvcGmkaYTpc44hd2ZiSFTBR{B4cXSqIFnDOVAhd2ZiMD61JO69VQ>?MnnhNVk{PDRzN{W=
SHSY5YNVLERpNsS3m2b4TvfIlkKEG|c3H5NFTpbmcyOCEQvF2=Ml:xOFghcA>?NHHMboxFVVORMXrJR|UxRTJizszNNH70O5IyQTN2NEG3OS=>
DMS114M{TVWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MojtOFghcA>?NWPVNmlvT0l3ME2yMlkh|ryPMnrlNVk1OTl{MEW=
HBC5M4\4O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX:4e5hnPDhiaB?=MnzPS2k2OD1zNzFOwG0>MkjCNVk1OTl{MEW=
SNB78NH;kOGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEfuS2c1QCCqM2rYTmdKPTB;MU[g{txONXnNO5hbOTl2MUmyNFU>
HeLaMnvqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MojWO|IhcA>?M1nmV2ROW09?Mn;0TWM2OD1yLkS2JO69VQ>?MknUNVk1PDF6NE[=
BHKMomwT4lv[XOnIFHzd4F6MXi1JO69VQ>?NFy4VFUzPCCqMoXHSG1UVw>?MWjJcohq[mm2aX;uJI9nKEiGQVO3JIV5eHKnc4Pl[EBie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDwcIF{dWFibXXtZpJidmViRnTlcJRiPTB6IFPGWHIheHKxdHXpci=>M4XPeVE6QTZ4N{i5
CFBE41o-MoL0T4lv[XOnIFHzd4F6MlS2OUDPxE1?NIrPeYI5KGh?MXLEUXNQNYPLPGgyUW6qaXLpeIlwdiCxZjDISGFEKGG|c3Xzd4VlKGG|IHj5dIVz[WOndInsZZRqd25ib3[gbIl{fG:wZTDINy=>MnHNNVk6PjZ5OEm=
CFBE41o-NX7OXYhFU2mwYYPlJGF{e2G7NYP2T4tNPSEQvF2=NVviW|lzPCCqNFfUOHdFVVORNGnwenJKdmirYnn0bY9vKG:oIFjERWMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gcZV1[W62IF\k[Yx1[TVyODDDSnRTKHC{b4TlbY4hdGW4ZXy=NIrFO40yQTl4Nke4PS=>
CFBE41o-MYHLbY5ie2ViQYPzZZk>MUWxJO69VQ>?MnHQNUBpM4H3UmROW09?NFvQcnJKdmirYnn0bY9vKG:oIFjERWMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gR2ZVWiCycn;0[YlvKGyndnXsNH\QXJMyQTl4Nke4PS=>
Primary bronchial epithelial cellNXv5S5FyU2mwYYPlJGF{e2G7NWqxVoZQOSEQvF2=NEntbJczPCCqNIj3VZBFVVORMVfJcohq[mm2aX;uJI9nKEiGQVO3JIF{e2W|c3XkJIF{KGmwZIXjeIlwdiCxZjDteZRidnRiRnTlcJRiPTB6IFPGWHIheHKxdHXpckBieGmlYXygd5Vz\mGlZTDsc4NidGm8YYTpc44>M{PrRlE6QTZ4N{i5
CFBE41o-MlvST4lv[XOnIFHzd4F6Mkm0NUDPxE1?NE[4U442KGSjeYO=M171emROW09?M1XZW2lvcGmkaYTpc44hd2ZiSFTBR|ch[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gd5Ri[mmuaYrheIlwdiCxZjDG[IVtfGF3MEigR2ZVWiCycn;0[YlvMWGxPVk3Pjd6OR?=
CFBE41o-NWDpNFJzU2mwYYPlJGF{e2G7MljSNUDPxE1?Mn7LNlQhcA>?MYjEUXNQMVzJcohq[mm2aX;uJI9nKEiGQVO3JIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIF\k[Yx1[TVyODDDSnRTKHC{b4TlbY4hfHKjZn\pZ4tqdmd?NYT0VmNqOTl7Nk[3PFk>
CFBE41o-MXnLbY5ie2ViQYPzZZk>M4jNVVUh|ryPM2TzR|I1KGh?MmO5SG1UVw>?M1jVfmlvcGmkaYTpc44hd2ZiSFTBR|ch[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gdoF1\SCxZjDtZZR2emG2aX;uJI9nKEOIVGKgdJJwfGWrbjD0c{BqfHNiZ3z5Z49nd3KvNFTtXIcyQTl4Nke4PS=>
CFBE41o-NU\EOodlU2mwYYPlJGF{e2G7NX\HclZQPSEQvF2=Mlv3NlQhcA>?NF73[XpFVVORMXvJcohq[mm2aX;uJI9nKEiGQVO3JIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIIP0ZYJqdGm2eTDv[kBH\GWudHG1NFghS0[WUjDwdo91\WmwMkexNVk6PjZ5OEm=
CFBE41o-M37teGtqdmG|ZTDBd5NigQ>?MkLVOUDPxE1?MYKyOEBpMn7RSG1UVw>?MlHBTY5pcWKrdHnvckBw\iCKRFHDO{Bie3Onc4Pl[EBieyClb4Ly[YN1cW:wIH;mJI12fGGwdDDG[IVtfGF3MEigR2ZVWiC2cnHm[olkc2mwZzD0c{Bk\WyuIIP1doZi[2ViYYOg[4x6[2:ob4LtMknXNVk6PjZ5OEm=
Primary bronchial epithelial cellNVHKVVYyU2mwYYPlJGF{e2G7MYm1JO69VQ>?NYTsdod4OjRiaB?=NXLjUYZCTE2VTx?=NELwfZhKdmirYnn0bY9vKG:oIFjERWMh[XO|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJI12fGGwdDDG[IVtfGF3MEigR2ZVWiCycn;0[YlvKGGyaXPhcEB{fXKoYXPlJIxw[2GuaYrheIlwdg>?M4HT[|E6QTZ4N{i5
Primary bronchial epithelial cellNGHxem5McW6jc3WgRZN{[Xl?NUe2SGhHOSEQvF2=NIjEZ206PiCqMkSySG1UVw>?NFH4NFJKdmirYnn0bY9vKG:oIFjERWM4KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJJNpd3K2IHPpdoN2cXRiY4XydoVvfHN?Ml6wNVk6PjZ5OEm=
BxPC3Ml:wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmezO|IhcA>?NX\3Um12UUN3ME2yMlch|ryPMWiyNFE1Ozd5OB?=
CAL27MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUCyZnUyPzJiaB?=M1fjSWlEPTB;Mz63NkDPxE1?M{XabFIxOTR|N{e4
Capan1MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXi3NkBpNUHLV5pxUUN3ME23MlMh|ryPNWf4NmJQOjBzNEO3O|g>
HCC827NY\KbGtQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvndHM6PzJiaB?=NUniOZhnUUN3ME2xMlgh|ryPM2nPOlIxOTR|N{e4
LNCAPM1e4NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYq3NkBpNUm2TGxQUUN3ME2wMlU5KM7:TR?=NXvVTYJZOjBzNEO3O|g>
NCI-H2122NVX0WY9tT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnPFO|IhcA>?NFHNRZlKSzVyPUeuOUDPxE1?NGfpV5EzODF2M{e3PC=>
NCI-H358MoTYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVrsZXNUPzJiaB?=NVvSbJg4UUN3ME2yMlUh|ryPM{PCUVIxOTR|N{e4
SCC15MlLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFvMZWU4OiCqNWKyOnpUUUN3ME2yMlQ6KM7:TR?=NWTBcXNEOjBzNEO3O|g>
SCC25MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4jBSVczKGh?NUDjV446UUN3ME2xMlk{KM7:TR?=M4HXZ|IxOTR|N{e4
SKHEP1NGHWTopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGPkWGc4OiCqMXXJR|UxRTNwNE[g{txOMmn4NlAyPDN5N{i=
BJNFHBbJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml7sNVAxKM7:TR?=M13Dd|Q5KGh?NGLp[2VFVVORMVXHdo94fGhiaX7obYJqfGmxbjDheEAxNjB3IITvJFExOCC3TR?=NYfYe2J7OjBzNEO4OFA>
MUFM1K4Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml7tNVAxKM7:TR?=MnXmOFghcA>?MkXnSG1UVw>?MlHrS5Jwf3SqIHnubIljcXSrb36gZZQhOC5yNTD0c{AyODBidV2=M3nmV|IxOTR|OESw
Caco-2NWL1clBIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NY\SfHQzOTByIN88US=>MoW5OFhpMmi0SG1UVw>?M3PLd2lEPTB;OD6xJO69VQ>?NUfPZXprOjBzNEO4OFA>
Caco-2NUHCT|FSU2mwYYPlJGF{e2G7NEe5fXk2KM7:TR?=M{nwOlQhcA>?NUnrdnJiTE2VTx?=MoX0TY5lfWO2aX;uJI9nKEiGQVOtcYVlcWG2ZXSgbIl{fG:wZTDhZ4V1gWyjdHnvckBKSzVyIH;mJFAvODN5IN88US=>MUCyNFE1Ozh2MB?=
Caco-2Mn7GT4lv[XOnIFHzd4F6NVnwTWhrOC5|MU[gcm0hfG9iM{GuOkDPxE1?NUi2e|dNPCCqNVHCWY9bTE2VTx?=MUnFfEB3cX[xIHnubIljcXSrb36gc4YhcHWvYX6gTGRCSzFid3n0bEBKSzVyIH;mJFAvOTF7IN88US=>M1K4eFIxOTR|OESw
Caco-2MY\LbY5ie2ViQYPzZZk>NYjuTGR{OC5|MU[gcm0hfG9iM{GuOkDPxE1?NVvFd4V6PCCqMX7EUXNQM4fMTmV5KH[rdn:gbY5pcWKrdHnvckBw\iCqdX3hckBJTEGFMzD3bZRpKEmFNUCgc4YhOC5zNEeg{txOM4HOZlIxOTR|OESw
Caco-2MlrFT4lv[XOnIFHzd4F6NH64d4s3NjN{IH7NJJRwKDZ|MjFOwG0>MljxOEBpMkHFSG1UVw>?M{D1d2V5KH[rdn:gbY5pcWKrdHnvckBw\iCqdX3hckBJTEGFNTD3bZRpKEmFNUCgc4YhOTJwNjFOwG0>NHLkNnozODF2M{i0NC=>
Caco-2NUn4ZWV4U2mwYYPlJGF{e2G7NE\FbnA3NjN{IH7NJJRwKDZ|MjFOwG0>MmeyOEBpMkK5SG1UVw>?NH\zUoZGgCC4aY\vJIlvcGmkaYTpc44hd2ZiaIXtZY4hUESDQ{ege4l1cCCLQ{WwJI9nKDRzIN88US=>MoTwNlAyPDN6NEC=
Caco-2NI\SZlNMcW6jc3WgRZN{[Xl?NGPvNVkxNjNzNjDuUUB1dyB|MT62JO69VQ>?NHv5Xng1KGh?NWPhSng2TE2VTx?=MUTFfEB3cX[xIHnubIljcXSrb36gc4YhcHWvYX6gTGRCSzZ?NHvBRlMzODF2M{i0NC=>
HepG2MlnkT4lv[XOnIFHzd4F6NHrKb5E2KM7:TR?=NXy1TlZIPmh?M1zreWROW09?MWTJcoR2[3Srb36gc4YhUESDQz3t[YRq[XSnZDDobZN1d26nIHHj[ZR6dGG2aX;uM3W5dlIxOTR|OESw
HepG2Mo\YT4lv[XOnIFHzd4F6MoD6OUDPxE1?M{fUR|ZpMoTzSG1UVw>?MVPJcoR2[3Srb36gc4YhUESDQz3t[YRq[XSnZDDobZN1d26nIHj5dIVz[WOndInsZZRqd25?NHTKXIYzODF2M{i0NC=>
HepG2M2fw[GtqdmG|ZTDBd5NigQ>?NVK2WXhEPSEQvF2=MUC2bC=>MWHEUXNQM2DofGlv\HWldHnvckBw\iCKRFHDMY1m\GmjdHXkJIFteGijLYT1ZpVtcW5iYXPleJlt[XSrb36=NHHjd2szODF2M{i0NC=>
HepG2MXjLbY5ie2ViQYPzZZk>MnLOOUDPxE1?MUi2bC=>NV;iTph4TE2VTx?=MWjJcoR2[3Srb36gc4YhUESDQz3t[YRq[XSnZDDIN{9JPCCqaYP0c45mKGGlZYT5cIF1cW:wM{nqPFIxOTR|OESw
COLO205MWTLbY5ie2ViQYPzZZk>M3jYc|ExKM7:TR?=M2TrbFI1KGh?Ml;oSG1UVw>?NVH5WWZYUW6qaXLpeIlwdiCxZjDISGFEOSCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhcGm|dH;u[UBJOyCjY3X0fYxifGmxbjD3bZRpKEmFNUCgc4YhOi5{IN88US=>MVmyNFQ2OTN5OB?=
SCC4NU\DWnFiU2mwYYPlJGF{e2G7NH:zdmQyKM7:TR?=M3z1fFI1cA>?MW\Jcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5idIXieYxqdiCjY3X0fYxifGmxbh?=NFvORoMzODR3MkKyOS=>
SCC4NWnYTJlYU2mwYYPlJGF{e2G7NXu4O4R6OSEQvF2=M4TocVI1cA>?NVryOmtoUW6qaXLpeIlwdiCxZjDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgZYNmfHmuYYTpc44>NYjrPVRvOjB2NUKyNlU>
SCC4NIfZVG9HfW6ldHnvckBCe3OjeR?=MXSxJO69VQ>?MornOUBucW5?MWHB[49vcXO2IHHjeIl3cXS7IHH0JHZFWiCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhS1mSMkSg[4Vv\SCneIDy[ZN{cW:wM1;PXFIxPDV{MkK1
NB4NV\sW3VWTnWwY4Tpc44hSXO|YYm=M4q3U|Uh|ryPNUX3N|BYOjRiaB?=MXLEUXNQNIfIdJhE\WyuIHP5Z4xmKGG{cnXzeEBie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDhZ4N2dXWuYYTpc44h[XRicILlMWcyKHCqYYPlMYmyNFQ6OTR2MB?=
NB4NXnvOHlCU2mwYYPlJGF{e2G7NYm4Z2ViPSEQvF2=NXjNc4U{OjRiaB?=NXTOe3RvTE2VTx?=MUPJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iYXPleJlt[XSnIIT1ZpVtcW5ibHX2[Yw>NYTHdIs6OjB2OUG0OFA>
NB4M2CwN2Z2dmO2aX;uJGF{e2G7MoPyOUDPxE1?NUDPVFFjOjRiaB?=M4GyNmROW09?MnvGTY5lfWO2aX;uJI9nKHB{MWfBSlEwS0mSMTDlfJBz\XO|aX;uMVyyNFQ6OTR2MB?=
NB4M3rpZmtqdmG|ZTDBd5NigQ>?MlzFOUDPxE1?M3P1dFI1KGh?M2PIbWROW09?MVjJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iaHnzeI9v\SCKMzDhZ4V1gWyjdHnvci=>M{DIe|IxPDlzNESw
NUGC3NVjFempLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHHSPGVIUTVyPUKuPVQh|ryPMVWyNFg2ODl5MR?=
A549NUTpdoczTnWwY4Tpc44hSXO|YYm=Ml7WOUDPxE1?NUTFNHVSOyCqM1u0WGROW09?Ml36TY5lfWO2aX;uJI9nKGG3dH;wbIFogSCrbjDoeY1idiCDNUS5JINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKEyFM1nJNUGz[GxuOjB6NUWyNFg>
HUT78NUKycWUxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mmf3O|IhcA>?NYW0UnRnTE2VTx?=NUnuO|dDT0l3ME2wMlMh|ryPNHLzXVIzODh6NEKwPC=>
U937NY\rS2UzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGTZTHk4OiCqMWXEUXNQMYPHTVUxRTBwM{mg{txONV\Ze2ZUOjB6OESyNFg>
A431MUHDfZRwfG:6aXOgRZN{[Xl?NXHs[mg{PzJiaB?=NFzOUVlEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCPDNzIHPlcIx{KG:4ZYLlfJBz\XO|aX7nJGVITlJid3n0bEBKSzVyIH;mJFQvOiEQvF2=MUOyNVA5ODZ{OR?=
A549M3zSO2N6fG:2b4jpZ{BCe3OjeR?=Ml:wO|IhcA>?MVjDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJI93\XKneIDy[ZN{cW6pIFjERWMhf2m2aDDJR|UxKG:oIEGuPEDPxE1?NH;iUnczOTB6ME[yPS=>
CAL27NIr6WlJEgXSxdH;4bYMhSXO|YYm=NUDqfHZqPzJiaB?=MlzNR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gR2FNOjdiY3XscJMhd3[ncnX4dJJme3OrbnegSWdHWiC5aYToJGlEPTBib3[gN{4zKM7:TR?=M1PTTVIyODhyNkK5
HeLaMkTHR5l1d3SxeHnjJGF{e2G7NHrFOZg4OiCqMnS0R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTIVN[SClZXzsd{BwfmW{ZYjwdoV{e2mwZzDISGFEKHerdHigTWM2OCCxZjCxMlUh|ryPMn3kNlExQDB4Mkm=
Sf21NH\LNphMcW6jc3WgRZN{[Xl?NXm2UpY4OyCqNWTvVI9yUW6qaXLpeIlwdiCxZjDGcIFoKHSjZ3fl[EBpfW2jbjDy[YNwdWKrbnHueEBJTEGFODDlfJBz\XO|ZXSge4l1cCCLQ{WwJI9nKDFwMjFOwG0>M2\MVVIyODhyNkK5
SKBR3NI\R[XJEgXSxdH;4bYMhSXO|YYm=NIDwZWY4OiCqNIXTV2hEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUU0KUMzDj[YxteyCxdnXy[ZhxemW|c3nu[{BJTVJ{IIfpeIghUUN3MDDv[kAzNjZizszNMlHwNlExQDB4Mkm=
SKOV3MljTR5l1d3SxeHnjJGF{e2G7MorIO|IhcA>?M1zZNGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHNMV1Z|IHPlcIx{KG:4ZYLlfJBz\XO|aX7nJGhGWjJid3n0bEBKSzVyIH;mJFIvOiEQvF2=NX7wfGJDOjFyOEC2Nlk>
COR-L23MmDPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NG\vfYEyOCEQvF2=NXnJbohLPzJiaB?=Mn2zSG1UVw>?NHHnPXhIUTVyPUGuNUDPxE1?NEfsdYszOTB6ME[0Oy=>
DU145M2HmU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWnqfHFtOTBizszNMn[wO|IhcA>?M2T5UmROW09?M{\zVWdKPTB;MT6wOUDPxE1?NIH5ZVgzOTB6ME[0Oy=>
LoVoM4C0V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVnWd4x[OTBizszNMmrBO|IhcA>?Mn;USG1UVw>?MlPUS2k2OD1zLkeg{txOM3XCVVIyODhyNkS3
MCR5-SV2Mk\tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUKxNEDPxE1?M1PNbFczKGh?M4L1PGROW09?NGHlbXNIUTVyPUKuNUDPxE1?M1rJ[lIyODhyNkS3
HCT116NXO2[pRFU2mwYYPlJGF{e2G7NYLmW2tOOzBizszNNH;4XZM{OCCqMWPEUXNQM1G0WGlvcGmkaYTpc44hd2ZiSFTBR|Yh[XO|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJIFteGijLYT1ZpVtcW5iYXPleJlt[XSrb36=M{\WbFIyODhyNkS3
HCT116MX\LbY5ie2ViQYPzZZk>M4PWdVMxKM7:TR?=NITYOms{OCCqNH3sUXBFVVORNGXqR|BKdmirYnn0bY9vKG:oIFjERWMyKGG|c3Xzd4VlKGG|IHnu[JVkfGmxbjDv[kBpcXO2b37lJGg{UzliYXPleJlt[XSrb36=NIW3R5UzOTB6ME[0Oy=>
U937M4nWdWtqdmG|ZTDBd5NigQ>?M33aV|Uh|ryPNWHTdYJHOjRiaB?=M2LIZ2ROW09?NHr1ZotKdmirYnn0bY9vKG:oIHjpd5RwdmViYXPleJltfHKjboPm[ZJie2ViYYPz[ZN{\WRiYYOgbY5kemWjc3Wgc4Yh[WOndInsZZRqd25ib3[gbIl{fG:wZTDIN{BifCCNOR?=MlrWNlEzQTJ2OUK=
U937M{[zUmtqdmG|ZTDBd5NigQ>?NELsW|Q2KM7:TR?=MmK2NlQhcA>?NEnxdWxFVVORMlfXTY5pcWKrdHnvckBw\iCqaYP0c45mKGGlZYT5cJRz[W6|ZnXyZZNmKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIH;mJIFk\XS7bHH0bY9vKG:oIHjpd5RwdmViSEOgZZQhUzF6MXOyNVI6OjR7Mh?=
U937M4HlNmtqdmG|ZTDBd5NigQ>?M3LkS|Uh|ryPMnzlNlQhcA>?MljYSG1UVw>?NF\wVXVKdmirYnn0bY9vKG:oIHjpd5RwdmViYXPleJltfHKjboPm[ZJie2ViYYPz[ZN{\WRiYYOgbY5kemWjc3Wgc4YheGGwLXHj[ZR6dGG2ZXSgbIl{fG:wZTDIOEBt\X[nbB?=MWWyNVI6OjR7Mh?=
U937MkTqT4lv[XOnIFHzd4F6MmXEOUDPxE1?NF\WfFAyPSCvaX6=MX7EUXNQMWHJcohq[mm2aX;uJI9nKGirc4TvcoUh[WOndInseJJidnOoZYLhd4Uh[XO|ZYPz[YQh[XNiaX7jdoVie2Vib3[gbIl{fG:wZTDIN{Bi[2W2eXzheIlwdiCuZY\lcC=>NFfUSIUzOTJ7MkS5Ni=>
A2780NHzn[YtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV65OkBpM1S3cGROW09?NX[yeYNkUUN3ME2xMlYzKM7:TR?=MkfaNlE3OzR2M{C=
COLO205NXq4dpNCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnT2PVYhcA>?MV7EUXNQNInOUJRKSzVyPUKuNVIh|ryPMVSyNVY{PDR|MB?=
Hep3BMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlfEOFghcA>?NIOwWXVFVVORMWnHTVUxRTFwMkGg{txOMYSyNVcyOjF2Nh?=
GM11272MmTLSpVv[3Srb36gRZN{[Xl?M2rWZ|ExOCCwTR?=NH\teZc4OiCqNEXkTWpFVVORNFfpeVlT\WGldHn2ZZRqd25ib3[gUYVEeDJibYX0ZY51KGW6cILld5Nqd25iYYSgNVAhfG9iMUCwJI5OMW[yNVg1ODdzNh?=
CFBE41oNWHiNGhUU2mwYYPlJGF{e2G7Ml\GOUDPxE1?NIXI[XhFVVORNVv2bGZsTG:5bjDy[Yd2dGG2aX;uJI9nKEiGQVO3JIF1KDBwMjD0c{A2KHWPNHK0UmQzOTl6NEm1PC=>
CFBE41oNIXUe|JHfW6ldHnvckBCe3OjeR?=NV;rfI1yOSEQvF2=M1HuW|I1KGh?MnLPSG1UVw>?NIHCRndT\XO2b4LheIlwdiCxZjDDSnRTKGSnbIThSlUxQCCvdYThcpQhfHKjZn\pZ4tqdmdidH:gZ4VtdCC|dYLmZYNmKGG|IHfsfYNw\m:{bYO=MlXlNlE6QDR7NUi=
DU145M1:yb2tqdmG|ZTDBd5NigQ>?MWKyMlUh|ryPNVnQd21zOjRiaB?=MYfEUXNQMkjlTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W|c3XkJIF{KHWycnXneYxifGmxbjDv[kBxOjG5YX[xJJBzd3SnaX6g[ZhxemW|c3nvci=>NXz0OVRjOjJ{NkCxOlY>
DU145M2XFWGtqdmG|ZTDBd5NigQ>?M4e3N|Uh|ryPM33McFI1KGh?NGGxU4xFVVORM{HWOWlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCqaYP0c45mKEh2IHHj[ZR6dGG2aX;uMWKyNlI3ODF4Nh?=
DU145M4XuOWtqdmG|ZTDBd5NigQ>?M1HZclUh|ryPMUCyOEBpNXqyToRJTE2VTx?=MUnJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcGm|dH;u[UBJOyCqeYDldoFk\XS7bHH0bY9vMl3sNlIzPjBzNk[=
786-0M3e4V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYjoNYZWPi5{IN88US=>M4\We|czKGh?M4nibmROW09?Mn2yS2k2OD1|LkKg{txOM1v5SlIzPDN3Nk[5
A498MoO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3n6[|YvOiEQvF2=NV:1XWJMPzJiaB?=M33DU2ROW09?MXnHTVUxRTFwNjFOwG0>M4H5RVIzPDN3Nk[5
A549/ATCCNUnVb4ZHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1z1O|YvOiEQvF2=Mn3WO|IhcA>?NVj0N2t3TE2VTx?=NVu0[phtT0l3ME2xMlYh|ryPMn3JNlI1OzV4Nkm=
ACHNNVLtcox1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmHJOk4zKM7:TR?=NVTpR3JTPzJiaB?=MYTEUXNQMXHHTVUxRTFwMzFOwG0>MkLmNlI1OzV4Nkm=
BT549NFvBNmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVLzV2RwPi5{IN88US=>MmDnO|IhcA>?M3L0cWROW09?MWXHTVUxRTFwMzFOwG0>M1\mRVIzPDN3Nk[5
EKVXNFnBV29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVqxToFlPi5{IN88US=>NUmw[3o3PzJiaB?=MnPNSG1UVw>?Ml7yS2k2OD1zLkOg{txOMUKyNlQ{PTZ4OR?=
HCT15MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFO5UZo3NjJizszNNX3O[nJRPzJiaB?=NIThTo5FVVORNHfINodIUTVyPUKuOUDPxE1?M4XCV|IzPDN3Nk[5
HOP92NWS0UIJFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUi2MlIh|ryPNYPsW216PzJiaB?=MXjEUXNQNFTtUmNIUTVyPUSg{txONWi5XoQ3OjJ2M{W2Olk>
IGROV1MlzRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYC2MlIh|ryPNHjYfY04OiCqMl3zSG1UVw>?MW\HTVUxRTFwMzFOwG0>NHvub3IzOjR|NU[2PS=>
LOXIMVINETnSHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYi2MlIh|ryPMnrsO|IhcA>?M1PLeGROW09?NIPtVohIUTVyPUGg{txONXLoTG5IOjJ2M{W2Olk>
M14NFjEfoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2rWS|YvOiEQvF2=M4\Kc|czKGh?NWHuZ2liTE2VTx?=M37Ub2dKPTB;MT6zJO69VQ>?NUfJWHg4OjJ2M{W2Olk>
MALME-3MM1zlVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{LRUlYvOiEQvF2=MnSwO|IhcA>?M13mRmROW09?NGfxTpNIUTVyPUCuN|Ih|ryPMn\FNlI1OzV4Nkm=
MCF10AM3zEfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MorlOk4zKM7:TR?=M4TQS|Q5KGh?MljNSG1UVw>?MWrHTVUxRTlwNjFOwG0>NUnZenV7OjJ2M{W2Olk>
MDA-MB-435NX\vcFNpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGrF[pI3NjJizszNMlHCO|IhcA>?NELnb2FFVVORMWDHTVUxRTBwNTFOwG0>NHzzbWMzOjR|NU[2PS=>
MDA-MB-468MonaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEj2WIE3NjJizszNNHnsU|Q4OiCqMVfEUXNQM2LmfGdKPTB;MD62N{DPxE1?MknMNlI1OzV4Nkm=
MOLT4NEPIO3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYDuTHZYPi5{IN88US=>MmPGO|IhcA>?MX;EUXNQM4PoS2dKPTB;MD60JO69VQ>?MXOyNlQ{PTZ4OR?=
NCI-ADR-RESNEi0TG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGnEVnQ3NjJizszNM1HuW|czKGh?MULEUXNQMlLuS2k2OD1yLkG2JO69VQ>?M3e4VFIzPDN3Nk[5
NCI-H23M13LV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUK2MlIh|ryPNFvLdlM4OiCqMlXQSG1UVw>?MVPHTVUxRTFizszNM1fWXFIzPDN3Nk[5
NCI-H322MNGn4R3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV\tOmdkPi5{IN88US=>NEXtVZA4OiCqNFrJXlhFVVORMUPHTVUxRTBwN{mg{txOMmryNlI1OzV4Nkm=
NCI-H460M3q4T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX62cVZGPi5{IN88US=>M3TEOFczKGh?MojmSG1UVw>?M{ThTGdKPTB;MD63PUDPxE1?MXmyNlQ{PTZ4OR?=
NCI-H522NWOyVJVnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkD0Ok4zKM7:TR?=NYfycoNiPzJiaB?=M376XGROW09?MWHHTVUxRTBwNTFOwG0>NU\zbnhDOjJ2M{W2Olk>
OVCAR3MmPtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVXZNnBuPi5{IN88US=>NInOfpE4OiCqM2\wO2ROW09?M1TZb2dKPTB;MT6zJO69VQ>?Ml3LNlI1OzV4Nkm=
OVCAR4MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX[2MlIh|ryPMlWyO|IhcA>?NH3aSmhFVVORMWPHTVUxRTRizszNNGXv[4szOjR|NU[2PS=>
OVCAR5M4nob2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHLJR|Y3NjJizszNNGD0R5c4OiCqMlyxSG1UVw>?NYr2d4lmT0l3ME2wMlc6KM7:TR?=MV[yNlQ{PTZ4OR?=
OVCAR8NFXBfHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{D0RlYvOiEQvF2=NWSwTolKPzJiaB?=M3jtSWROW09?NFnZeGVIUTVyPUCuOUDPxE1?MU[yNlQ{PTZ4OR?=
RXF393MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGS2UJQ3NjJizszNNGXnbZE4OiCqMl7aSG1UVw>?NHTYPW9IUTVyPUGuN{DPxE1?M4XifVIzPDN3Nk[5
SF268MoHsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rJUlYvOiEQvF2=NFLxVJk4OiCqNXLsVowzTE2VTx?=M3P0SGdKPTB;MT62JO69VQ>?M1XXUlIzPDN3Nk[5
SF295MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXm2MlIh|ryPNGXxWHg4OiCqM1e4XGROW09?MXLHTVUxRTFwNjFOwG0>NXrtPXV4OjJ2M{W2Olk>
SF539M3Tt[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmXkOk4zKM7:TR?=NEPHRVk4OiCqNH;xTVhFVVORNUPZe|FMT0l3ME2yJO69VQ>?MXSyNlQ{PTZ4OR?=
SK-MEL-2MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mo\tOk4zKM7:TR?=M{jYW|czKGh?M1XsWmROW09?NH71[pNIUTVyPUGuN{DPxE1?MnPzNlI1OzV4Nkm=
SK-MEL-28NFnROW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPEcnVYPi5{IN88US=>M1zQ[VczKGh?MlO3SG1UVw>?MUPHTVUxRTFizszNMVeyNlQ{PTZ4OR?=
SK-MEL-5NVTKdHR3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlT1Ok4zKM7:TR?=MoPqO|IhcA>?M1uydWROW09?NWHJOpk6T0l3ME2wMlY{KM7:TR?=NIDBSoMzOjR|NU[2PS=>
SKOV3MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoTTOk4zKM7:TR?=NYL4cVc3PzJiaB?=NHflRVZFVVORMYrHTVUxRTFizszNMmfYNlI1OzV4Nkm=
SN12CNFL6e|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEXGfGU3NjJizszNM3vDPVczKGh?M1;0[GROW09?NY[xcpVnT0l3ME2yJO69VQ>?MkfNNlI1OzV4Nkm=
SNB19NGrOdYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4\oU|YvOiEQvF2=MWe3NkBpMYDEUXNQNHX4NHBIUTVyPUCuOlMh|ryPM1\6fVIzPDN3Nk[5
SNB75M4m2TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYS2MlIh|ryPMkXBO|IhcA>?NUiz[G96TE2VTx?=M{fhUGdKPTB;MD63PUDPxE1?Mn;iNlI1OzV4Nkm=
SRNHvGOoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXZNJM3NjJizszNMV23NkBpNX\4VGpiTE2VTx?=NVXwRo9XT0l3ME2wMlQh|ryPM1PpRlIzPDN3Nk[5
T47DNGTHXVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2DGe|YvOiEQvF2=Mmn3O|IhcA>?NGnUbY5FVVORNV7ERXRET0l3ME2wMlUh|ryPM{X2PVIzPDN3Nk[5
TK10M3q2OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn\5Ok4zKM7:TR?=NVfs[GpFPzJiaB?=MkXSSG1UVw>?MmLIS2k2OD1yLk[zJO69VQ>?NFu1fZgzOjR|NU[2PS=>
UACC257MknCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYLkOYQzPi5{IN88US=>NGnSN2c4OiCqNH3GZXJFVVORMmTKS2k2OD1yLkWg{txONHHaWpozOjR|NU[2PS=>
UACC62MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYK2MlIh|ryPM4rSelczKGh?NX\ITWN4TE2VTx?=MV7HTVUxRTBwNDFOwG0>NU\0dW9jOjJ2M{W2Olk>
UO31M{DhdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYi2MlIh|ryPNYLkWJZMPzJiaB?=MlvuSG1UVw>?M{XkNWdKPTB;MD61JO69VQ>?NHLYO|gzOjR|NU[2PS=>
Hep3BNV\PUYxOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXv3Vop3PDhiaB?=NIfwT5JFVVORMUjHTVUxRTBwNkmg{txOM4n5bFIzPDN7OE[z
BE(2)-CNHTnflBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIGzbpE4OiCqMUXEUXNQMnfxTWM4OD1{IN88US=>NIHuUVEzOjl|MkOxOi=>
Bel7402NILudppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{DPUVczKGh?MoXVSG1UVw>?NHnJSXNIUTlyPUG3JO69VQ>?NHT0S3MzOzB4MUO3Oi=>
Bel7404MmHnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWi3NkBpMoTESG1UVw>?NI[xToZIUTlyPUG4JO69VQ>?M{\L[|I{ODZzM{e2
BGC823MnuyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlHXO|IhcA>?NILPXnpFVVORNXzTdog3T0l7ME23MlUh|ryPMnzSNlMxPjF|N{[=
MGC803MnHjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1T5UVczKGh?NIfKVVFFVVORMXvHTVkxRTFyLkig{txOMXWyN|A3OTN5Nh?=
SGC7901MoD0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEjGcmw4OiCqNGC5b5VFVVORM3\WO2dKQTB;OT60JO69VQ>?MoW2NlMxPjF|N{[=
SKHEP1MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF[yVYU4OiCqNVfOO4s1TE2VTx?=MofzS2k6OD1zNzFOwG0>NFzi[oszOzB4MUO3Oi=>
SMMC7721Ml;hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH;VSYc4OiCqNGXQNIdFVVORMVzHTVkxRTJyIN88US=>M{XOcVI{ODZzM{e2
NUGC3M2PufWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVyxNEDPxE1?MVjHTV0zNjl2IN88US=>NGjLPYkzOzF4M{OzNi=>
A2780 CisRNYTYVnVrU2mwYYPlJGF{e2G7M4DMPFE5KGh?NXSyd5F4UW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlQ1KM7:TR?=NVLkS4V2OjN{NUK2NFM>
CAL27 sensNIe5dGNMcW6jc3WgRZN{[Xl?NIXGcYIyQCCqNWT6OFI4UW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlM3KM7:TR?=NUD0UHZrOjN{NUK2NFM>
CAL27 CisRM37sRWtqdmG|ZTDBd5NigQ>?MlnjNVghcA>?M1zUV2lvcGmkaYTpc44hd2ZiSFTBR{B4cXSqIFnDOVAhd2ZiMD62NUDPxE1?NHKyOJczOzJ3Mk[wNy=>
KYSE-510 CisRM4rsdWtqdmG|ZTDBd5NigQ>?MlfPNVghcA>?NUfPcIsxUW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlU6KM7:TR?=M1rLUlI{OjV{NkCz
KYSE-510 sensM2jMZ2tqdmG|ZTDBd5NigQ>?M4nXWlE5KGh?NFrnb2xKdmirYnn0bY9vKG:oIFjERWMhf2m2aDDJR|UxKG:oIECuO{DPxE1?NED6dFMzOzJ3Mk[wNy=>
MDA-MB-231 sensM1zzRmtqdmG|ZTDBd5NigQ>?M2W3bVE5KGh?M3jWcmlvcGmkaYTpc44hd2ZiSFTBR{B4cXSqIFnDOVAhd2ZiMD62NUDPxE1?NYnlUpRDOjN{NUK2NFM>
MDA-MB-231 CisRNWXaflV[U2mwYYPlJGF{e2G7MUOxPEBpNWOxcGI2UW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlYyKM7:TR?=MVyyN|I2OjZyMx?=
ES2NF\IcFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF3OPGI1QCCqMmPHSG1UVw>?NWPYZ3p3UUN3ME2xNk44KM7:TR?=M4DRfFI{PDl|NES5
MDA-MB-231MlewT4lv[XOnIFHzd4F6NF:2eIIyOCEQvF2=NGLsenM{OCCvaX6=M4XG[GROW09?MW\Jcohq[mm2aX;uJI9nKEiGQVOyZS=>MXmyN|Q6OzR2OR?=
MDA-MB-231M3jCOmtqdmG|ZTDBd5NigQ>?Mkm5NUDPxE1?MWSyOEBpNWD1enlYTE2VTx?=MULJcohq[mm2aX;uJI9nKEiGQVO2JIF{e2W|c3XkJIF{KGGlZYT5cIF1cW:wIHzleoVteyCxZjD0eYJ2dGmwNXvHc|hVOjN2OUO0OFk>
HS68MWrDfZRwfG:6aXOgRZN{[Xl?MknLNVAh|ryPNUTpfJFiPzJiaB?=Mof4SG1UVw>?MWrJR|UxRTRwNjFOwG0>MlL3NlM2PzB3NEK=
MEFMlfaR5l1d3SxeHnjJGF{e2G7NIS5OJcyOCEQvF2=MnSxO|IhcA>?NXy0WVBKTE2VTx?=Mmm0TWM2OD12LkSg{txOM33UelI{PTdyNUSy
BGC823MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4jFdWROW09?M4XleWdKPTB;Mz6wPUDPxE1?MlvrNlM3ODF5ME[=
High5MXXLbY5ie2ViQYPzZZk>MVeyOEBpMWrJcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEiGQVO2JJdqfGhiSVO1NEBw\iByLkC5JO69VQ>?M4roc|I{PjB{NUKz
High5M4no[WtqdmG|ZTDBd5NigQ>?MYOyOEBpMlm3TY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCKRFHDNUB4cXSqIFnDOVAhd2ZiMD6xNkDPxE1?NYq4UIZuOjN4MEK1NlM>
High5NVzn[3o1U2mwYYPlJGF{e2G7NXjQU|FwOjRiaB?=NVTvbnhLUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEOyC5aYToJGlEPTBib3[gNE4yPyEQvF2=M{XzOVI{PjB{NUKz
A549NH;5SWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFPjbFhFVVORMWLJR|UxRTFwMEe5JO69VQ>?MoXBNlM3PDR{MUC=
HCT116NGjzdmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlT3SG1UVw>?NYD3W4lbUUN3ME2wMlc2PyEQvF2=MlXPNlM3PDR{MUC=
K562NXXWcoxET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXEUXNQNY\KTZhDUUN3ME2wMlY1PSEQvF2=M4fQTlI{PjR2MkGw
GBC-SDMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXnlOZNZPSEQvF2=NXnnPI9KPzJiaB?=M1jtXGROW09?NIjPWpVKSzVyPUG0Mlgh|ryPNF7lOJYzOzdyN{K2NC=>
HGC27M1TwTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVe3V4tQPSEQvF2=Mnu1O|IhcA>?NHXTcVhFVVORM1\rOmlEPTB;NT60JO69VQ>?MorjNlM4ODd{NkC=
HL60MXfLbY5ie2ViQYPzZZk>Moj5OUDPxE1?M{G2VlI1KGh?NWDqblVQTE2VTx?=MoXETY5pcWKrdHnvckBw\iCKRFHDM4\RV|I{PzB5Mk[w
VeroMnvjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1;GUFczKGh?MlnTSG1UVw>?M{P2TWlEPTB;MD65JO69VQ>?M2HJZ|I{Pzh4NEWy
NCI60MlPOR5l1d3SxeHnjJGF{e2G7NYjLUIE6PDhiaB?=NWnOXGExTE2VTx?=NV[2eZF{T0l;MD61N{DPxE1?MlXhNlQxOTV|Mke=
SW620MmDPR5l1d3SxeHnjJGF{e2G7NVHVdolGPDhiaB?=M4X2[WROW09?MVfHTV0xNjV2IN88US=>MlG1NlQxOTV|Mke=
U251NWrRO2ZIS3m2b4TvfIlkKEG|c3H5NETr[2w1QCCqNXO0PFVnTE2VTx?=M4fuWWdKRTFwNUOg{txONXL2XJo3OjRyMUWzNlc>
KM12M3u4N2N6fG:2b4jpZ{BCe3OjeR?=M1f2UlQ5KGh?M122[GROW09?M3LyZ2dKRTFwOEig{txOM2mwO|I1ODF3M{K3
Hs578TMUPDfZRwfG:6aXOgRZN{[Xl?M{D6RVQ5KGh?M4PDUGROW09?NYXyS|ZHT0l;ND64N{DPxE1?MmjJNlQxOTV|Mke=
MDA-MB-231MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4LXUFQ5KGh?MUHJR|UxRTBwMU[g{txOM{nFfVI1ODl3MEG2
MCF7NEDifm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV3HVnFjPDhiaB?=NV7nS2pbT0l;MD60OUDPxE1?M3q4VlI1OTF7NUW1
MDA-MB-435NX;Xco1KT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHPmNFU1QCCqNVvIfoJrT0l;MD64PEDPxE1?NV;ofVVnOjRzMUm1OVU>
AsPC1M1zVRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2PhUFMxKM7:TR?=NYLHSHc5PDhiaB?=M3zlUWROW09?NFHaZ4xKSzVyPUOuOlYh|ryPNW\kUYJkOjRzOEWzO|g>
Jurkat E6.1NWfGUWU6U2mwYYPlJGF{e2G7NWPicnpyOiCqM{[3V2ROW09?NXXzNHhKUW6qaXLpeIlwdiCxZjDISGFEPCC5aYToJGlEPTBib3[gNE4xPCEQvF2=M37vO|I1OjZzOE[y
KG1NXz0XZlET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NULVRXl7PDhiaB?=MlLwTWM2OD1zLkG1JO69VQ>?NXLPd29[OjR3MkWwNFM>
HELNGLQO2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1m3VFQ5KGh?M{TkdmROW09?M3TGXGlEPTB;MD60PUDPxE1?NGHzRXIzPDZ7NEC1OS=>
HSC3M3fuTWN6fG:2b4jpZ{BCe3OjeR?=NGnxZpMyOiCqNV75eYtzTE2VTx?=M2SxTWlEPTB;MD63NUDPxE1?MlnjNlQ4PjZ3NkC=
HT-29MWXDfZRwfG:6aXOgRZN{[Xl?MX:xNkBpM3eyNWROW09?NF62dFhKSzVyPUCuO|Ih|ryPMV6yOFc3PjV4MB?=
KBM3;hT2N6fG:2b4jpZ{BCe3OjeR?=M3W0WlEzKGh?NX;VUGczTE2VTx?=Ml6xTWM2OD1yLke1JO69VQ>?MleyNlQ4PjZ3NkC=
H460NVzBcJdkS3m2b4TvfIlkKEG|c3H5M4f4VlEzKGh?M{HtdWROW09?MY\JR|UxRTBwOEKg{txONXm4V2F3OjR5Nk[1OlA>
MONE1MnfGR5l1d3SxeHnjJGF{e2G7MUOxNkBpNEnpWYdFVVORNIK2[5VKSzVyPUGuNVgh|ryPM4XBPVI1PzZ4NU[w
MKN45MYHDfZRwfG:6aXOgRZN{[Xl?NFi0XosyOiCqM1:yW2ROW09?MnnGTWM2OD1zLkK1JO69VQ>?MknNNlQ4PjZ3NkC=
TSGHMV7DfZRwfG:6aXOgRZN{[Xl?MVuxNkBpNUDvcXJSTE2VTx?=M3frbGlEPTB;Mj6wPUDPxE1?NGLVO|kzPDd4NkW2NC=>
HL60MnHmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmTGO|IhcA>?M176OWROW09?NVrUdmZFT0l3ME2wMlk{KM7:TR?=NEjjdpEzPDlyMEWwNC=>
HEK293NVLDSoF[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnL1O|IhcA>?NHz3ZmFFVVORM3rK[mdKPTB;MUOg{txOMkfMNlQ6ODB3MEC=
JurkatNIe0Zo9EgXSxdH;4bYMhSXO|YYm=MlnRNVAxKM7:TR?=NUnTXWw4PzJiaB?=Ml3xS2k2OD1yLkmg{txONY\1XoU6OjR7MEC3OFM>
GM15850MlfCT4lv[XOnIFHzd4F6NUG5dZVOOi53IN88US=>MoS4PVYhcA>?NYeweZQ3TE2VTx?=M3XnToRw\XNibn;0JIlvcGmkaYSgTGRCSyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBpcXO2b37lJGg{KGy7c3nu[UAyPCCjY3X0fYxifGmxbjDv[kBHYE5iZ3Xu[S=>M{fHdVE3QTJzM{[3
GM15850M37UWmtqdmG|ZTDBd5NigQ>?NHfleJYzNjVizszNM2rtcVk3KGh?NYTGflFjTE2VTx?=M{LifIRw\XNibn;0JIlvcGmkaYSgTGRCSyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBpcXO2b37lJGg1KGy7c3nu[UA2KGGlZYT5cIF1cW:wIH;mJGZZViCpZX7lNXPJUZI{OTZ7MkGzOlc>
GM15850M3y0TWtqdmG|ZTDBd5NigQ>?NEL1cXEzNjVizszNNH;GdHk6PiCqNHrkSlVFVVORMXrkc4V{KG6xdDDpcohq[mm2IFjERWMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIOEBtgXOrbnWgNVIh[WOndInsZZRqd25ib3[gSnhPKGenbnW=M{PkRlE3QTJzM{[3
GM15850NHLkZ|BMcW6jc3WgRZN{[Xl?M2nzSlIvPSEQvF2=MXm5OkBpMV;EUXNQMnKw[I9meyCwb4SgbY5pcWKrdDDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFMhdHm|aX7lJFkh[WOndInsZZRqd25ib3[gSnhPKGenbnW=NFH4XJYyPjl{MUO2Oy=>
GM15850NV7pe|JqU2mwYYPlJGF{e2G7NGDESJEzNjVizszNM3vxW|k3KGh?MkjHSG1UVw>?NUDsW4Fy\G:nczDuc5QhcW6qaXLpeEBJTEGFIHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGirc4TvcoUhUDRibInzbY5mKDhiYXPleJlt[XSrb36gc4YhTliQIHflcoU>M1faflE3QTJzM{[3
GM15850M2K2WGtqdmG|ZTDBd5NigQ>?MWCyMlUh|ryPMXW5OkBpNFHvb4lFVVORMkLn[I9meyCwb4SgbY5pcWKrdDDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm|aX7lJFE3KGGlZYT5cIF1cW:wIH;mJGZZViCpZX7lNWHYelg2OTZ7MkGzOlc>
GM15850MXrGeY5kfGmxbjDBd5NigQ>?MoP5OUDPxE1?NHLD[2UyOiCqM2TJcWROW09?NIjBT5Bp[XNibn:g[YZn\WO2IH;uJGZZViCvUl7BJIV5eHKnc4Ppc44>Mn\4NVY6OjF|Nke=
U937M2Hw[2tqdmG|ZTDBd5NigQ>?MWK1JO69VQ>?NEHwcJIzPCCqNGXxe4NFVVORMWroZZMhdm9iZX\m[YN1KG:wIHHsdIhiKHS3YoXsbY4h[WOndInsZZRqd25?NFTnOGgyPzR2N{e1NC=>
U937MXHLbY5ie2ViQYPzZZk>NEOzbZYyKM7:TR?=Mk[xNlQhcA>?NVKye412TE2VTx?=M1G3NIhieyCwbzDl[oZm[3Rib36gZYxxcGFidIXieYxqdiCjY3X0fYxifGmxbh?=NFTVT3EyPzR2N{e1NC=>
PANC1M3G4O2Z2dmO2aX;uJGF{e2G7NVjQVFlOOSEQvF2=Mn7KNlQhcA>?MlPE[I9meyCwb4SgbY5kemWjc3WgbY4heDJ5a3nwNUBo\W6nIHX4dJJme3Orb36=MnvONVc2QDh5NES=
PANC1NXi2TIVoTnWwY4Tpc44hSXO|YYm=M4i0N|Eh|ryPMlziOFghKGh?M2HEd4Rw\XNibn;0JIlv[3KnYYPlJIlvKHB{N3vpdFEh\2WwZTDlfJBz\XO|aX;uNVr5W2ZUOTd3OEi3OFQ>
Caco-2MkDmSpVv[3Srb36gRZN{[Xl?MkLSOUDPxE1?NVG5PYo3OjRiaB?=NYPrO2pbTE2VTx?=MlnE[I9meyCwb4SgbY5lfWOnIGCyNXdCTjFiZ3Xu[UBmgHC{ZYPzbY9vMWmyNFE1Ozh2MB?=
SCC4MkiySpVv[3Srb36gRZN{[Xl?Mm\vNUDPxE1?NXviOWtKOTBibXnuMoDFSG1UVw>?MmrTbIF{KG6xIHHnc45qe3RiYXP0bZZqfHliYYSgWmRTKGG|c3Xzd4VlKGG|IHnu[JVkfGmxbjDv[kBEYVB{NDDn[Y5mKGW6cILld5Nqd25?M{PSb|IxPDV{MkK1
A549MX;GeY5kfGmxbjDBd5NigQ>?NITjc|I2KM7:TR?=MVGzJIg>NGXqWJZFVVORNXfi[ol5\G:nczDuc5QhcW6mdXPlJIF2fG:yaHHnfUBie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDMR|NKUQ>?Mn;zNlA5PTV{MEi=
HCT116NXL1UGl3U2mwYYPlJGF{e2G7NH36VJIxNjNizszNM3H3fFMxKGh?NUmxeo9LTE2VTx?=MWrkc4V{KG6xdDDpcohq[mm2IFjERWMyKGG|c3Xzd4VlKGG|IHnu[JVkfGmxbjDv[kBpcXO2b37lJGg{UzliYXPleJlt[XSrb36=NEPhVYEzOTB6ME[0Oy=>
HepG2M17xRmZ2dmO2aX;uJGF{e2G7MkT0NVAh|ryPMnTENlQhcA>?NUDJ[2NsTE2VTx?=NVX3NHN5\G:nczDuc5QhcW6mdXPlJIFxd3C2b4Ppd{Bie3Onc4Pl[EBieyCqeYDldoFk\XS7bHH0bY9vKG:oIIC1Ny=>NIPuR3czOTV2OEW4Ni=>
GM11272M3XoXGZ2dmO2aX;uJGF{e2G7M{fheFAvOSEQvF2=MmO2O|IhcA>?MWjEUXNQNH;2d|lld2W|IH7veEBz\WGldHn2ZZRmKE2nQ4CyJI12fGGwdDDlfJBz\XO|aX;uMYeyNVg1ODdzNh?=
MDA-MB-231Ml;VT4lv[XOnIFHzd4F6MYKxNEDPxE1?NXLXbYFoPSCvaX6=NEXaRolFVVORNVjidYZs\G:nczDuc5QhcW6qaXLpeEBJTEGFMnG=M{jEPVI{PDl|NES5
MDA-MB-231NUXSU2hxU2mwYYPlJGF{e2G7Mor0NUDPxE1?MUCyOEBpM2q4cWROW09?MYrkc4V{KG6xdDDpcohq[mm2IFjERWM3KGG|c3Xzd4VlKGG|IHHj[ZR6dGG2aX;uJIxmfmWuczDv[kB1fWK3bHnuNIjSSFEzOzR7M{S0PS=>
K562M1Hz[WtqdmG|ZTDBd5NigQ>?M1zPT4Rw\XNibn;0JIlvcGmkaYSgTGRCSw>?Mn;ONlM2QTFzMUG=
JurkatMlu5R5l1d3SxeHnjJGF{e2G7NH7lV5UzOCEQvF2=MmnQO|IhcA>?NH[wW4JFVVORMVjuc{BkgXSxdH;4bYNqfHliYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36=NUHuTGRpOjR|MESzOFg>
HCT116NWHiS|RQSXCxcITvd4l{KEG|c3H5NUL6NIlJOyEQvF2=NWn2cGxOOjRiaB?=NVHwbIJDTE2VTx?=MXXkc4V{KG6xdDDpcoR2[2ViYYDvdJRwe2m|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKHB3MzDwdo91\WmwIHzleoVtMUGyOFc3PjV4MB?=
KASUMI-1MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXv1TZlRUUN3ME25PU4yPyCwTR?=M4H4[HNCVkeHUh?=
KARPAS-45NH3tUndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH65WYNKSzVyPUG3N{45QSCwTR?=NXi4eYpYW0GQR1XS
BHT-101NVLNdHZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1XpXGlEPTB;MkS0MlE5KG6PNEPEWGxUSU6JRWK=
H9MkXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkfSTWM2OD1{NUWuNFQhdk1?NVrRO5FYW0GQR1XS
PA-1MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NE\zRlRKSzVyPUK4Ok4zPiCwTR?=NVvtXZg3W0GQR1XS
NEC8MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXe1bnJqUUN3ME2yPFkvOzhibl2=M3TN[XNCVkeHUh?=
MHH-PREB-1NUWxfGJKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnXNTWM2OD1{OUSuOVMhdk1?NYWxcGttW0GQR1XS
NB7NXnZeFFrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXHJR|UxRTN2NT63OEBvVQ>?MYXTRW5ITVJ?
A3-KAWMkSzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoKwTWM2OD12MECuOVkhdk1?NVPMb|ZmW0GQR1XS
NB69NULxUYxpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYX5N5lLUUN3ME20NVEvPzFibl2=MmDvV2FPT0WU
EoL-1-cellMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGnTR4hKSzVyPUS1OFI2KG6PNVjCXWNVW0GQR1XS
CHP-212NHjIUGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYrnbIFEUUN3ME20OVcvPTNibl2=MojCV2FPT0WU
C2BBe1MoK3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlvUTWM2OD12N{KuNVkhdk1?NXnYN5lUW0GQR1XS
697MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYXjfnE3UUN3ME20O|MvPDFibl2=M1nEd3NCVkeHUh?=
BCPAPM3TjTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M17UN2lEPTB;NUCxMlQzKG6PM3P1RXNCVkeHUh?=
L-363NGTrVYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1P0dGlEPTB;NUCzMlEhdk1?MVfTRW5ITVJ?
ES8Mli1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUXJR|UxRTV{Mz61N{BvVQ>?M3HEVHNCVkeHUh?=
BE-13M2W0XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWfJR|UxRTV{Nj65OkBvVQ>?NV7xV2hbW0GQR1XS
CTB-1MkS0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2ToT2lEPTB;NUO3MlkzKG6PNYrpUFJUW0GQR1XS
HD-MY-ZMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEnXRolKSzVyPUWzPE4yOyCwTR?=NID6Z3hUSU6JRWK=
NKM-1MkXOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEP5fXlKSzVyPUW0OE4zPyCwTR?=M4Dk[3NCVkeHUh?=
NCI-H720NVX6b3BYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHTj[3VKSzVyPUW2NE4yQCCwTR?=MUXTRW5ITVJ?
KY821MnPDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTV4Mz6yOUBvVQ>?NVTQWmszW0GQR1XS
OVCAR-5M2f2Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIi2R2ZKSzVyPUW3Ok4yOSCwTR?=MUnTRW5ITVJ?
CTV-1M{HxZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXPlToppUUN3ME21PFEvPTZibl2=MVjTRW5ITVJ?
P12-ICHIKAWANWrtb|ZPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWXJR|UxRTV7Nj61NUBvVQ>?NUfhUYRpW0GQR1XS
DBMoKxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXTJR|UxRTV7OD61O{BvVQ>?M3LzXXNCVkeHUh?=
CHL-1NIe2fXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1TBWmlEPTB;NkSyMlA5KG6PNHTubpJUSU6JRWK=
A4-FukMoPoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXjJR|UxRTZ2ND65NUBvVQ>?NIP1RXZUSU6JRWK=
MV-4-11NXHKZ2FtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYTJR|UxRTZ3OT6xJI5ONHH0ZoVUSU6JRWK=
RPMI-8226M{fLS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEj0UJlKSzVyPU[3PE4yQCCwTR?=NWrWb4tqW0GQR1XS
NB14NV3GcmdvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX;JR|UxRTZ7Nj65OUBvVQ>?NYLIWZhDW0GQR1XS
DOHH-2M3r2V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml;sTWM2OD15ME[uOlghdk1?MnrMV2FPT0WU
D-423MGMkTWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGDKPW9KSzVyPUewOk45QSCwTR?=MUPTRW5ITVJ?
D-283MEDMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1rRW2lEPTB;N{G0MlE1KG6PNXy1V5dKW0GQR1XS
ES1NEPlfWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYjJR|UxRTd{ND60JI5ONX[2N5RoW0GQR1XS
GOTOMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4DoN2lEPTB;N{K5MlEzKG6PNXjNeVA3W0GQR1XS
NCI-H209NXHtSZNQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVLCXJdGUUN3ME23NlkvQSCwTR?=NXPRTmJ1W0GQR1XS
MOLT-13MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGnIXpdKSzVyPUezPE46QCCwTR?=NVm4eYpbW0GQR1XS
ATN-1M1jwTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\ISmlEPTB;N{SwMlI5KG6PNXvZW3FYW0GQR1XS
DU-4475M2rC[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUHxTZVKUUN3ME23OVEvQTFibl2=MX3TRW5ITVJ?
NB10MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH;QVIdKSzVyPUe1NU46OiCwTR?=MkfuV2FPT0WU
KG-1M4HrXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnftTWM2OD15N{WuOFUhdk1?NVf4eFBlW0GQR1XS
MOLT-4NVfGcFduT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4m5e2lEPTB;N{i3MlQ3KG6PMkH2V2FPT0WU
TE-1NWHncZZrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTd7MT6xJI5ONVO1VXFkW0GQR1XS
SBC-1NFe5U|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUfJR|UxRTd7Mz64OEBvVQ>?NIT1cmhUSU6JRWK=
HELNHX6fFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2\RTWlEPTB;OEC2MlA5KG6PMV\TRW5ITVJ?
SK-MEL-2M2TnTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXrJR|UxRThyOT60OEBvVQ>?M3;SPXNCVkeHUh?=
KU812NWHt[Y06T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVmxfmlHUUN3ME24NVMvOSCwTR?=MVzTRW5ITVJ?
RPMI-8866NGXDPHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIL1RWVKSzVyPUixN{43PyCwTR?=MXjTRW5ITVJ?
ALL-PONH;sWHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEPFe2dKSzVyPUixOE43PiCwTR?=M{PNe3NCVkeHUh?=
LU-139MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXXJR|UxRTh{Mj64OkBvVQ>?MUnTRW5ITVJ?
RS4-11M3rVUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NY\sVWVWUUN3ME24N|IvPDVibl2=Mo\iV2FPT0WU
EW-18NGnYOm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYfyPGwzUUN3ME24N|IvQTZibl2=M3L2NXNCVkeHUh?=
P30-OHKMnrJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFXzd4NKSzVyPUizOU44KG6PNIHnOI9USU6JRWK=
D-566MGMlvtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEfuRlFKSzVyPUizPE43OiCwTR?=NXfO[Io6W0GQR1XS
HSC-4Mo\JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{PP[GlEPTB;OES2MlUyKG6PNF23dYlUSU6JRWK=
QIMR-WILNFHzSG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEPrPYZKSzVyPUi2Nk4xOyCwTR?=MYTTRW5ITVJ?
SW954M1foTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFnOVnhKSzVyPUi2N{4yPiCwTR?=NVjaS|U3W0GQR1XS
HGC-27M1nCVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXvJR|UxRTh5Mj6zOEBvVQ>?M2XMdHNCVkeHUh?=
HHM4fzZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mm\3TWM2OD16OUSuNVIhdk1?MmHkV2FPT0WU
KE-37M1uyW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTh7ND62NkBvVQ>?NIfFcplUSU6JRWK=
SK-N-DZNFW4XFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGjscZdKSzVyPUmwNE41OyCwTR?=NYDlNIM2W0GQR1XS
J-RT3-T3-5NGfpOINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYnvRWJoUUN3ME25NVAvPDlibl2=NXfyZ4lVW0GQR1XS
A427NEPqcHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3nCTGlEPTB;OUKwMlg1KG6PM{mybXNCVkeHUh?=
ECC10NVzGN|VOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml7mTWM2OD17NEWuPFchdk1?M1roeXNCVkeHUh?=
EW-1M1\tUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIj1TXBKSzVyPUm0O{4zPiCwTR?=NHSyUVVUSU6JRWK=
MIA-PaCa-2NE[y[lZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVjJR|UxRTl2OT6xNkBvVQ>?M3jwcHNCVkeHUh?=
HCC2218NH7kRnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTl3OD60PEBvVQ>?NXTtSXlrW0GQR1XS
HAL-01MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NY\4PFB7UUN3ME25OlgvODRibl2=NF7ieldUSU6JRWK=
RDNGHXe4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV;QOoN3UUN3ME25O|QvPDVibl2=M365RnNCVkeHUh?=
SK-N-ASNYPZOFh[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3jGOmlEPTB;OUi4MlEhdk1?MkjaV2FPT0WU
ML-2NE\rc3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV3JR|UxRTFwMEC0NFch|ryPMUDTRW5ITVJ?
MEL-HOMVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYXJR|UxRTFwMEC1PFIh|ryPNYDZbZk1W0GQR1XS
MS-1Mn3CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTFwMEC2NVch|ryPMn;pV2FPT0WU
NCI-SNU-1MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTFwMEKzN|Eh|ryPMWXTRW5ITVJ?
8505CMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M13JVmlEPTB;MT6wNlM{OSEQvF2=M3nnNnNCVkeHUh?=
MN-60MlG0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnnjTWM2OD1zLkCyOlgh|ryPNEH0OlFUSU6JRWK=
SASMmLCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmT3TWM2OD1zLkC0NFgyKM7:TR?=MXrTRW5ITVJ?
EFM-19NGP2XlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXvJR|UxRTFwMES4O|kh|ryPNUD3OpBCW0GQR1XS
Ca9-22MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3nESGlEPTB;MT6wOVExPyEQvF2=MXjTRW5ITVJ?
NBsusSRM2DwVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGDmSXlKSzVyPUGuNFUyPjZizszNNVHQfJBsW0GQR1XS
NB13NX71[nc5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYe2S5VFUUN3ME2xMlA2PTBzIN88US=>MnfuV2FPT0WU
SF295NH\EfnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGfvTI1KSzVyPUGuNFY3OjRizszNM4jwOHNCVkeHUh?=
U-2-OSNGLiS5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV;aPGtCUUN3ME2xMlA4QTFzIN88US=>NHfmS2lUSU6JRWK=
NCI-H526MmKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIXwV2lKSzVyPUGuNFgzQTFizszNMl3YV2FPT0WU
KMOE-2MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWq3XmxHUUN3ME2xMlA6PDJ{IN88US=>M3nHSnNCVkeHUh?=
RCM-1NWO5W3VET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYTJR|UxRTFwMUKxNFIh|ryPMXHTRW5ITVJ?
MC116NHTFeW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFnGbpdKSzVyPUGuNVM3OjFizszNMoS1V2FPT0WU
NCI-H1092Mnn6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3nJSmlEPTB;MT6xOVQxPiEQvF2=NXvZN5FoW0GQR1XS
EW-3MnzVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{HXZWlEPTB;MT6xO|IyOiEQvF2=NH;JNm1USU6JRWK=
HCT-116M2DqS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn3HTWM2OD1zLkG3O|Uh|ryPNUXybW9LW0GQR1XS
MC-IXCM1XWV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEOwUXdKSzVyPUGuNVc5QDFizszNM125V3NCVkeHUh?=
LB1047-RCCNUXhfo0{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYDJR|UxRTFwMUizNVIh|ryPNHzDfIhUSU6JRWK=
VM-CUB-1M{PnTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NViwOIpNUUN3ME2xMlE6OTB6IN88US=>NX3i[3BIW0GQR1XS
NB5NXjWT3JMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1i3XGlEPTB;MT6xPVg2PiEQvF2=NV;wVmRGW0GQR1XS
SKG-IIIaNV;z[|FRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmHNTWM2OD1zLkKzOFY1KM7:TR?=NXPx[m83W0GQR1XS
HO-1-N-1NULrOVJpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGq5[lRKSzVyPUGuNlM5OzVizszNMWTTRW5ITVJ?
EFO-27MnTpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlvXTWM2OD1zLkK1NFQ{KM7:TR?=M3ftUXNCVkeHUh?=
MHH-NB-11NF\3ToZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWTzWGJGUUN3ME2xMlI5OzJ7IN88US=>NHzwUJhUSU6JRWK=
SW620NIC0[ldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUfJR|UxRTFwMkmwNVgh|ryPMnf2V2FPT0WU
MOLT-16NYjWem9yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3LDfWlEPTB;MT6yPVc6PyEQvF2=M{nCS3NCVkeHUh?=
NTERA-S-cl-D1M17Dbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHnKT|hKSzVyPUGuN|E4PjFizszNNHXpV4JUSU6JRWK=
VA-ES-BJNHnVfJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXL1Z5VnUUN3ME2xMlMzPDd5IN88US=>NUPa[XRZW0GQR1XS
HCC1419MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXnyU|FyUUN3ME2xMlM1ODJ5IN88US=>NYfQO3lGW0GQR1XS
NCI-H69M{\UVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3ziWmlEPTB;MT6zOFEyOiEQvF2=NFO3VotUSU6JRWK=
DELNXrKTpMyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVTJR|UxRTFwM{WxOlIh|ryPMkHlV2FPT0WU
LXF-289NEfHSWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWDXc5pkUUN3ME2xMlM2OjRizszNMlrXV2FPT0WU
EW-11NX7oSmZwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX;JR|UxRTFwM{[wNlYh|ryPNVP1dYRwW0GQR1XS
KP-4MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlHOTWM2OD1zLkO3NFg2KM7:TR?=NWrtcppYW0GQR1XS
NOS-1M{P0UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUX3Zoo2UUN3ME2xMlQyOTl2IN88US=>NX7rXW0yW0GQR1XS
SK-NEP-1NVizd3RbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHe2d2FKSzVyPUGuOFE3QTNizszNMYnTRW5ITVJ?
LAMA-84MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnvHTWM2OD1zLkSzPVQ2KM7:TR?=M{[xdXNCVkeHUh?=
ES5NIjMbZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVe1UpFPUUN3ME2xMlQ1OyEQvF2=MXXTRW5ITVJ?
HuO9M1[5bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXfJR|UxRTFwNEWzOlIh|ryPMmjVV2FPT0WU
COLO-684M{PWOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1zxOmlEPTB;MT60OlEyQCEQvF2=NFLlSpZUSU6JRWK=
EW-24NYLBW3dMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkTSTWM2OD1zLkS2OVMyKM7:TR?=MWXTRW5ITVJ?
BV-173NY\RV206T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXmTWM2OD1zLkS3NlkyKM7:TR?=NWLPcot[W0GQR1XS
NCI-H1770MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn60TWM2OD1zLkS4OVM3KM7:TR?=M2\MTHNCVkeHUh?=
HuP-T4NV7YSJM4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEfpeGpKSzVyPUGuOFk{KM7:TR?=MVPTRW5ITVJ?
TYK-nuMkPuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIPVbFVKSzVyPUGuOFk5PTFizszNM37YSHNCVkeHUh?=
YH-13MmrUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MULJR|UxRTFwNEm4PVQh|ryPNXrJNpJPW0GQR1XS
H4NUDkdGtTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3THXWlEPTB;MT61NFkyOiEQvF2=NIG4eFZUSU6JRWK=
OVCAR-8NVP4ZllTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIfYT4VKSzVyPUGuOVQ1PzdizszNNEnWOlZUSU6JRWK=
NCI-H23M4nieGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3H2fGlEPTB;MT61OFY1PSEQvF2=M3W3ZnNCVkeHUh?=
ES7MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFLCcYRKSzVyPUGuOVQ4PzNizszNNX7KW4ROW0GQR1XS
COR-L88M4r1U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4fKXWlEPTB;MT61OlQzPCEQvF2=M2nxZXNCVkeHUh?=
TI-73NHn6[pRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2m2PGlEPTB;MT61PVA3KM7:TR?=NVf3[IxjW0GQR1XS
RT-112MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXzw[2o1UUN3ME2xMlU6Ojh2IN88US=>M2HtNXNCVkeHUh?=
HuO-3N1M2flb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYfJR|UxRTFwNUmzPFUh|ryPMnz0V2FPT0WU
HC-1NI[0SGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYLRb2RwUUN3ME2xMlU6QDZ4IN88US=>M4nWWXNCVkeHUh?=
HT55NHG2UGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVjsbZhwUUN3ME2xMlY2OTNzIN88US=>NVXWSYhLW0GQR1XS
IA-LMMXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmDSTWM2OD1zLk[5Nlc5KM7:TR?=Mmm4V2FPT0WU
EM-2Mmi2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYPJR|UxRTFwN{CwNVQh|ryPMVrTRW5ITVJ?
MHH-ES-1NX3xOZkzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWfrU|BLUUN3ME2xMlcxPDN3IN88US=>NIDye3VUSU6JRWK=
CAL-27NYTDPItvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmrFTWM2OD1zLkewOlIyKM7:TR?=MV;TRW5ITVJ?
COLO-800MnfUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWX2XIw1UUN3ME2xMlcyOTd7IN88US=>NH7NS4FUSU6JRWK=
HCE-TM4XuOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTFwN{G1JO69VQ>?MkDxV2FPT0WU
CAMA-1NITnU|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnfKTWM2OD1zLkexPVcyKM7:TR?=NV75VGlHW0GQR1XS
LOXIMVIMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYDBeYNZUUN3ME2xMlczOTFizszNNVXr[opqW0GQR1XS
NH-12M1P0OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVjJR|UxRTFwN{K2PVEh|ryPNXzBeohUW0GQR1XS
TCCSUPNIT5ZoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmXmTWM2OD1zLkeyPFI6KM7:TR?=MW\TRW5ITVJ?
MDA-MB-361MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWnJR|UxRTFwN{OxOVch|ryPNV23cXRMW0GQR1XS
EW-16NEjSXpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYXFNXdiUUN3ME2xMlc1OTB5IN88US=>MlXFV2FPT0WU
SNU-423NGH0W|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTFwN{W4Nlch|ryPNFXPdY1USU6JRWK=
DaoyM{PwbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mk\6TWM2OD1zLke2N|E6KM7:TR?=MX7TRW5ITVJ?
ES4NFzKblhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{fXXmlEPTB;MT63PFc1OSEQvF2=NF;KVpVUSU6JRWK=
PFSK-1MmfFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGSxU5JKSzVyPUGuPFA{PyEQvF2=NETaRYpUSU6JRWK=
ES3MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUXqbIpRUUN3ME2xMlgzPjhzIN88US=>MlftV2FPT0WU
ONS-76NYq3Nm5qT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIT6bGFKSzVyPUGuPFI5QTdizszNNXXpbXhLW0GQR1XS
JVM-3MlO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnnHTWM2OD1zLki1OFUyKM7:TR?=M1zRUXNCVkeHUh?=
OS-RC-2MoLwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV3YbpluUUN3ME2xMlg4OTVzIN88US=>MYrTRW5ITVJ?
COLO-320-HSRMkjLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVT0eHQyUUN3ME2xMlg5OTl5IN88US=>M2fhTHNCVkeHUh?=
HNMkjDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYfIXnBOUUN3ME2xMlg5PzJ3IN88US=>NF:xWGxUSU6JRWK=
HTMlzYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHTjNFNKSzVyPUGuPFg6PDdizszNMn;IV2FPT0WU
LoVoMmrxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEPKfGtKSzVyPUGuPFk5OSEQvF2=NIfaUYhUSU6JRWK=
CGTH-W-1NH\6Zm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M17ae2lEPTB;MT64PVk1PiEQvF2=MmSyV2FPT0WU
NB6M3Hk[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWnlVFZ7UUN3ME2xMlkyOjl6IN88US=>MoLVV2FPT0WU
EW-22Mlr3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUfUVnBHUUN3ME2xMlkzQDh5IN88US=>MYfTRW5ITVJ?
ES6NX\LTJpGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUDJR|UxRTFwOUO2N|Eh|ryPNGT2OYFUSU6JRWK=
SCC-15NV36PZB4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{nsNGlEPTB;MT65N|gyQSEQvF2=M3PLSHNCVkeHUh?=
HL-60NXrTRmEzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NG\sUHRKSzVyPUGuPVM6ODJizszNNWPMOFM3W0GQR1XS
human HOP-92MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnP3TWM2OD1zLkm0NFY2KM7:TR?=MUXTRW5ITVJ?
SW626NITxc3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUfJR|UxRTFwOUS4PVkh|ryPMn;wV2FPT0WU
HEC-1NFHZcnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIXwbIhKSzVyPUGuPVU{PiEQvF2=NHHxdFRUSU6JRWK=
LB2241-RCCM{nVWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3:yUGlEPTB;MT65PFI{OSEQvF2=Mm\CV2FPT0WU
Ramos-2G6-4C10MmTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU[2c3RtUUN3ME2xMlk6PDl|IN88US=>NHP6WVdUSU6JRWK=
A101DM1O1bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYDJR|UxRTJwMkCzNFMh|ryPMoSwV2FPT0WU
NCI-H446NYHVTJJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2PWXWlEPTB;Mj6wOFU6QSEQvF2=NUH3W3V{W0GQR1XS
SBC-5MlnUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXPPU|lrUUN3ME2yMlA3OTR5IN88US=>MY\TRW5ITVJ?
HOSMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmP4TWM2OD1{LkC3OlU{KM7:TR?=MkTSV2FPT0WU
K5MoXqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWfiXW9mUUN3ME2yMlA4QDFzIN88US=>MkjqV2FPT0WU
HLEMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTJwMEi1Nlkh|ryPMY\TRW5ITVJ?
HSC-2MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFHsOZJKSzVyPUKuNVI5QThizszNM4PubnNCVkeHUh?=
LCLC-97TM1MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYTBTGxzUUN3ME2yMlE1PTh|IN88US=>M3nSU3NCVkeHUh?=
DMS-273Ml\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWDJR|UxRTJwMUS4N|ch|ryPNXLJXI1LW0GQR1XS
TE-8NFjqNHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUTvT49sUUN3ME2yMlE2PzZ3IN88US=>MXHTRW5ITVJ?
DSH1NXnMNXNzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2DvdWlEPTB;Mj6xOlM6QCEQvF2=NF[wfHNUSU6JRWK=
CAL-51Mlf2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2jNPWlEPTB;Mj6xOlY6QSEQvF2=MYfTRW5ITVJ?
IST-SL1NIHGOW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{jG[mlEPTB;Mj6xOlg1PCEQvF2=MmH5V2FPT0WU
GCTM4T4W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1HldmlEPTB;Mj6xO|c4KM7:TR?=MoDWV2FPT0WU
SW948MlvwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnTBTWM2OD1{LkG4OFU3KM7:TR?=M{\FVnNCVkeHUh?=
NOMO-1MkLuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUPJR|UxRTJwMUmzNVch|ryPM2WycHNCVkeHUh?=
C8166MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoH5TWM2OD1{LkKxN|M1KM7:TR?=NF7reGJUSU6JRWK=
OC-314Mk\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEDldlVKSzVyPUKuNlMzPTlizszNNV\sdpUyW0GQR1XS
CAL-39Mn:zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MU\JR|UxRTJwMkO2NlYh|ryPMlfVV2FPT0WU
MDA-MB-453MmXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1SzZWlEPTB;Mj6yOFI4PSEQvF2=NUn0[o9[W0GQR1XS
A673MmX2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NE\iO25KSzVyPUKuNlU5PjJizszNMYPTRW5ITVJ?
HTC-C3MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXvkblY2UUN3ME2yMlI3QDVizszNNFjtTVRUSU6JRWK=
NCI-H1666Mnj3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn;qTWM2OD1{LkK4NVEyKM7:TR?=MUjTRW5ITVJ?
PSN1NIfkO3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXi3copYUUN3ME2yMlI5QTF|IN88US=>NVXNeG5MW0GQR1XS
GI-1NFPKOW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXL5N4pkUUN3ME2yMlMxPTR|IN88US=>NWHFNo1{W0GQR1XS
HuH-7NXLjRolVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVXGdo5pUUN3ME2yMlMxPjN5IN88US=>MV7TRW5ITVJ?
JARMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MojXTWM2OD1{LkOxPVg4KM7:TR?=NVPld4p2W0GQR1XS
5637NV;vPItJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{LFdGlEPTB;Mj6zNlEzQSEQvF2=MniwV2FPT0WU
GB-1NIrSOGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3n2T2lEPTB;Mj6zNlM{PSEQvF2=MX;TRW5ITVJ?
KP-N-YSMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYXJR|UxRTJwM{K2NVUh|ryPMnSzV2FPT0WU
OAW-42NEDZ[nFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXG2PGRbUUN3ME2yMlM{PDF4IN88US=>M1OwcHNCVkeHUh?=
8-MG-BANVzKVmg6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIXOZm1KSzVyPUKuN|M6ODZizszNMn;sV2FPT0WU
RH-18MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkizTWM2OD1{LkO1NFIzKM7:TR?=M4TMSnNCVkeHUh?=
NCI-H1155MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn24TWM2OD1{LkO2O|I2KM7:TR?=MVXTRW5ITVJ?
NB17NF\hd|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1j4Z2lEPTB;Mj6zPFI1OyEQvF2=M2fYZ3NCVkeHUh?=
NCI-H1437NXTDWnJJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWKz[pY1UUN3ME2yMlQyQDd|IN88US=>NV;TPFRKW0GQR1XS
SN12CNUnuO2hOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4HjRWlEPTB;Mj60N|IyPCEQvF2=NHfQOpRUSU6JRWK=
HSC-3MlLIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWrJR|UxRTJwNES1NFkh|ryPM37NZXNCVkeHUh?=
GAMGNVzCSopvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFvNdINKSzVyPUKuOFQ2PjFizszNM1;JZ3NCVkeHUh?=
HT-1080MknNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkflTWM2OD1{LkS0PFY1KM7:TR?=M2LEdXNCVkeHUh?=
A549NGW1NGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWDJR|UxRTJwNES4PVMh|ryPMlm1V2FPT0WU
KNS-62NYHkc5ZDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWjJR|UxRTJwNEWwOlEh|ryPM1;1UHNCVkeHUh?=
YKG-1MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFrzbpVKSzVyPUKuOFU1OzdizszNMWHTRW5ITVJ?
LU-134-AMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTJwNEewNFgh|ryPNH7qcZNUSU6JRWK=
FADUNYTidWVjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUXLdFl4UUN3ME2yMlQ4OTZ{IN88US=>MmL1V2FPT0WU
TGBC11TKBM3\UZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTJwNEexO|ch|ryPNYC3dIhxW0GQR1XS
HT-3M4nnPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M33sV2lEPTB;Mj60PVU{PSEQvF2=MnXCV2FPT0WU
NCI-H2170NF;LTYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHjuemxKSzVyPUKuOVA2PDlizszNMlfzV2FPT0WU
Mo-TNGPxNItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Moe4TWM2OD1{LkWwPVI4KM7:TR?=Mn7uV2FPT0WU
CCRF-CEMNFX1NFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTJwNUOwOFMh|ryPMX\TRW5ITVJ?
KU-19-19MnLTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn3FTWM2OD1{LkWzOVE{KM7:TR?=MV;TRW5ITVJ?
NCI-H1048MkjIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4fobmlEPTB;Mj61OVAzPSEQvF2=MVzTRW5ITVJ?
KOSC-2NWXuSVd4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkLwTWM2OD1{LkW2NFc3KM7:TR?=MXfTRW5ITVJ?
A431MnjOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIS3NXlKSzVyPUKuOVY{OzVizszNM{KzXXNCVkeHUh?=
COR-L23NGPhV41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlHYTWM2OD1{LkW4OVY3KM7:TR?=Mk\ZV2FPT0WU
MKN28MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M17OfGlEPTB;Mj61PVA{PyEQvF2=MlrjV2FPT0WU
22RV1NF7YT2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXLJR|UxRTJwNUmyO|Qh|ryPM3f5SnNCVkeHUh?=
ABC-1MmC4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYTJR|UxRTJwNkC0OkDPxE1?NFfkVHZUSU6JRWK=
NCI-H2126MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlrzTWM2OD1{Lk[wPVg1KM7:TR?=MkHLV2FPT0WU
DoTc2-4510NEjPeJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmrETWM2OD1{Lk[yNVg2KM7:TR?=MUjTRW5ITVJ?
SCC-4M3XiPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn7rTWM2OD1{Lk[zNFEzKM7:TR?=M122RXNCVkeHUh?=
NCI-H661NH20TYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3\VfmlEPTB;Mj62OFA5PSEQvF2=MnLRV2FPT0WU
RPMI-2650NXHkRZJOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUe2UYk2UUN3ME2yMlY1OTR|IN88US=>NGjMdpFUSU6JRWK=
NCI-H510AMk\wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmnuTWM2OD1{Lk[0OFI3KM7:TR?=M3G4[3NCVkeHUh?=
BPH-1M3;FWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{fNcGlEPTB;Mj62OVg2KM7:TR?=M2DUSXNCVkeHUh?=
M14MlzMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmG3TWM2OD1{Lk[2PVk{KM7:TR?=NWHU[mNYW0GQR1XS
G-402MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MljETWM2OD1{LkewOFUyKM7:TR?=NGToem9USU6JRWK=
AsPC-1MonuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX;JR|UxRTJwN{GxO{DPxE1?MorhV2FPT0WU
NB12NV[4c2o1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGTM[JpKSzVyPUKuO|E4OSEQvF2=NEXwPIdUSU6JRWK=
SK-HEP-1NHLrdmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFPjSWRKSzVyPUKuO|Q{QTFizszNNEHQe|FUSU6JRWK=
U-266NFLr[GNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlizTWM2OD1{Lke3NVIyKM7:TR?=NGnzfmdUSU6JRWK=
AM-38MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlThTWM2OD1{Lke3N|U2KM7:TR?=MXLTRW5ITVJ?
PC-14MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF;nNpFKSzVyPUKuPFA2OSEQvF2=NF7hOo1USU6JRWK=
EGI-1NYW4OIdCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIPmbXpKSzVyPUKuPFE4PDNizszNMUPTRW5ITVJ?
LS-411NM3fyXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnLBTWM2OD1{LkiyN|Mh|ryPMo\PV2FPT0WU
BFTC-905NUnIelNxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXzJR|UxRTJwOEW1NlMh|ryPNID4eWZUSU6JRWK=
CaR-1NWXzcFhZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4f0bGlEPTB;Mj64OkDPxE1?M4L1TXNCVkeHUh?=
NCI-H292NHSz[I1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4nNc2lEPTB;Mj64OlU6PiEQvF2=NETseZhUSU6JRWK=
8305CM17YXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUnvcJVsUUN3ME2yMlg3PjR3IN88US=>NVG2OmszW0GQR1XS
SNU-449NUCzfVUxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTJwOEmxPFIh|ryPMXrTRW5ITVJ?
LCLC-103HMmj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NITVPHhKSzVyPUKuPVA1OzhizszNMV7TRW5ITVJ?
SW1573NWDOVI5lT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTJwOU[wPFIh|ryPNYPKS2Z3W0GQR1XS
MLMAMX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2O0ZWlEPTB;Mj65OlcyPyEQvF2=NFK5fnNUSU6JRWK=
NCI-H1355NYPkTI5QT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHv0NohKSzVyPUOuNFA4QTZizszNM4Wzb3NCVkeHUh?=
RMG-IMULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1zmT2lEPTB;Mz6wNlU6OiEQvF2=MYHTRW5ITVJ?
BB65-RCCMWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTNwMEOzNVQh|ryPMWjTRW5ITVJ?
PC-3MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIXsTG5KSzVyPUOuNFM5PzRizszNMmnwV2FPT0WU
SF268M{L5PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NITWeVhKSzVyPUOuNFQ2OjNizszNNGDCUXRUSU6JRWK=
NCI-H810MlXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkDsTWM2OD1|LkC0PFI{KM7:TR?=NIXScJpUSU6JRWK=
MEG-01NYTPdWlqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2DUemlEPTB;Mz6wOlE3PCEQvF2=NV3SVm5oW0GQR1XS
SW13MmrJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVXBVWMyUUN3ME2zMlA4QDR5IN88US=>NVLNS5ZuW0GQR1XS
RH-1MkSwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXLJR|UxRTNwMUCyO|gh|ryPM3;y[XNCVkeHUh?=
GT3TKBM1zJSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH7wZo9KSzVyPUOuNVEzQDNizszNMYrTRW5ITVJ?
TK10NIHkO5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlraTWM2OD1|LkGzO|I1KM7:TR?=NXjQN4xkW0GQR1XS
T-24M2rOdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXsO|RKSzVyPUOuNVUxPyEQvF2=NVXTUZVtW0GQR1XS
A498NVfLcYZ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{jlemlEPTB;Mz6yNFg4OSEQvF2=NXTQ[WpGW0GQR1XS
GR-STM{HBfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV;JR|UxRTNwMkKxN|kh|ryPNVKzTWhHW0GQR1XS
LB2518-MELMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnnETWM2OD1|LkKyN|k5KM7:TR?=MY\TRW5ITVJ?
T47DNEHl[JdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlXaTWM2OD1|LkKzOlI4KM7:TR?=NF3tWZpUSU6JRWK=
NCI-H1651M4W0WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NInXTmhKSzVyPUOuNlQ3PDRizszNM171TnNCVkeHUh?=
EC-GI-10NIjPRoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2DObGlEPTB;Mz6yOlE2OyEQvF2=M{\DcHNCVkeHUh?=
HT-29MmPXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NI[wWHhKSzVyPUOuNlY3OTRizszNMWHTRW5ITVJ?
GI-ME-NNIPMWWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn\oTWM2OD1|LkK5OVEyKM7:TR?=NHfOb29USU6JRWK=
SW756NGfZNoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{DpSGlEPTB;Mz6yPVYzQSEQvF2=M1fNdHNCVkeHUh?=
RKONWX4R4tQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX\JR|UxRTNwM{C3OVch|ryPMVPTRW5ITVJ?
NCI-H1563MnrnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXnrXWFuUUN3ME2zMlM{ODF6IN88US=>NFTBNJJUSU6JRWK=
DJM-1M{T4PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV\JR|UxRTNwM{e2O|Qh|ryPNWLTN4d7W0GQR1XS
L-428NVzzZ5p4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LjfWlEPTB;Mz60NFA1PSEQvF2=Mn\nV2FPT0WU
NCI-H2122M{jafWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIrqemJKSzVyPUOuOFE{OTJizszNNIHiVJRUSU6JRWK=
Ca-SkiMlnsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnviTWM2OD1|LkS1OFMh|ryPMonPV2FPT0WU
639-VMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmP1TWM2OD1|LkS2NFU4KM7:TR?=Mn;0V2FPT0WU
SW1116M{Lx[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NILueFJKSzVyPUOuOFYzPjlizszNM1nhc3NCVkeHUh?=
DMS-114MnXpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnzlTWM2OD1|LkS3NFY3KM7:TR?=NWHUSXNrW0GQR1XS
MZ2-MELMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MojuTWM2OD1|LkS3OlgyKM7:TR?=M3\5SXNCVkeHUh?=
COLO-829MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHVTWM2OD1|LkWwNFc{KM7:TR?=MlX2V2FPT0WU
J82MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnnVTWM2OD1|LkWwOVch|ryPNY\FVmRKW0GQR1XS
EW-13MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2PLb2lEPTB;Mz61NlUyKM7:TR?=Ml3HV2FPT0WU
RXF393MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXr2PIxMUUN3ME2zMlU{Ojl2IN88US=>M3GxU3NCVkeHUh?=
CAL-62NH;qbZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUXCcWFjUUN3ME2zMlU1PTF2IN88US=>M4TubXNCVkeHUh?=
OCUB-MNIqxTpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoezTWM2OD1|LkW0OlY2KM7:TR?=M2r0Z3NCVkeHUh?=
BT-474NWjye4pGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnfYTWM2OD1|Lk[zN|Eh|ryPNUCySppwW0GQR1XS
KYSE-180MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlT6TWM2OD1|Lk[zN|czKM7:TR?=Mm\VV2FPT0WU
NCI-H650NXHzSJZRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MofBTWM2OD1|Lk[0Nlg4KM7:TR?=NHzkeVhUSU6JRWK=
Detroit562MmfQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MknMTWM2OD1|Lk[1NFIzKM7:TR?=NH6wR4ZUSU6JRWK=
SW48NGjHOHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlrVTWM2OD1|Lk[1OlU4KM7:TR?=MkLrV2FPT0WU
KYSE-450NXT0fmV{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk\PTWM2OD1|Lk[4OVgzKM7:TR?=NUjQeJlMW0GQR1XS
KYSE-510M1rKe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH:2XZRKSzVyPUOuO|IyQDFizszNM4PlcnNCVkeHUh?=
GP5dMmHMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn[zTWM2OD1|LkeyPVUh|ryPMWLTRW5ITVJ?
RPMI-7951MnTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYWyV|JlUUN3ME2zMlc1PzJ|IN88US=>MULTRW5ITVJ?
BeckerMnHlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1[zZWlEPTB;Mz63OVAyOiEQvF2=MXjTRW5ITVJ?
WM-115MojpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkeyTWM2OD1|Lke4NVk2KM7:TR?=NXXF[|doW0GQR1XS
G-401NVnqdo1UT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mo\VTWM2OD1|Lke5NFg2KM7:TR?=M4f2XnNCVkeHUh?=
PANC-08-13NYDqTJhGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnXBTWM2OD1|Lke5OlAzKM7:TR?=MWDTRW5ITVJ?
SW982MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX3yPGl[UUN3ME2zMlgxPTVzIN88US=>NXfXPIExW0GQR1XS
D-263MGNH2wW45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlPrTWM2OD1|LkiyNFUyKM7:TR?=MlL5V2FPT0WU
KM-H2MkC1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXTYc4xGUUN3ME2zMlgzPjJ2IN88US=>MUPTRW5ITVJ?
SK-MEL-3NH[4WGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXjJR|UxRTNwOEK4OFEh|ryPMXHTRW5ITVJ?
NCI-H1581NIL5UWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HKSmlEPTB;Mz64OFQ5QCEQvF2=NUHKXnJqW0GQR1XS
LS-123NXHYZWpNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV\JR|UxRTNwOEe5NFkh|ryPNV7jOm5uW0GQR1XS
CAKI-1NWXqNHdET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUDJR|UxRTNwOEmwOVIh|ryPM33jSXNCVkeHUh?=
MEL-JUSOM2fGemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2nxOGlEPTB;Mz64PVE2OyEQvF2=NY\I[IptW0GQR1XS
HCE-4MmDwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mlm3TWM2OD1|LkmxOlY{KM7:TR?=MmnSV2FPT0WU
TE-10NGDZR5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3rpeGlEPTB;Mz65NlAyKM7:TR?=M330U3NCVkeHUh?=
OVCAR-4MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFKxXHFKSzVyPUOuPVI5QDlizszNM1rMe3NCVkeHUh?=
ETK-1M{HPRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkTUTWM2OD1|Lkm0OlM2KM7:TR?=MVXTRW5ITVJ?
A2780NVXQcmlLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{PGU2lEPTB;ND6wOVk3PiEQvF2=MnrRV2FPT0WU
LU-65MnXyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NELldXZKSzVyPUSuNFc3OzNizszNMVPTRW5ITVJ?
BHYMYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzITm13UUN3ME20MlEzPDl3IN88US=>MY\TRW5ITVJ?
COR-L105NID2RYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn3NTWM2OD12LkGzNFUyKM7:TR?=NES3S|BUSU6JRWK=
CAL-12TM3LZ[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVjJR|UxRTRwMUOxNFMh|ryPMlTvV2FPT0WU
SCHNXvFXW1bT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGXndoxKSzVyPUSuNVU4PDNizszNNUO2NZh5W0GQR1XS
CW-2NUjCS4hrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUTJR|UxRTRwMUmwNFEh|ryPNHvMR3BUSU6JRWK=
HCC1806M3f1cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVnJR|UxRTRwMkCzNVIh|ryPM1\BcHNCVkeHUh?=
KP-N-YNM1zYVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGHMNZVKSzVyPUSuNlA6OjdizszNM2nZOnNCVkeHUh?=
T98GNV\CcFRjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MULJR|UxRTRwMkKxOVch|ryPMVvTRW5ITVJ?
CAL-54MlW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoC4TWM2OD12LkKyN|gyKM7:TR?=NEf2T2xUSU6JRWK=
CAL-33MnvmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1fGdWlEPTB;ND6yN|A3PCEQvF2=MXPTRW5ITVJ?
SNU-C2BMl7PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2\2WGlEPTB;ND6yOFc3QSEQvF2=MWTTRW5ITVJ?
NUGC-3MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVzJR|UxRTRwMkW1NFUh|ryPM2XETHNCVkeHUh?=
DOKMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnXSTWM2OD12LkK2OVk{KM7:TR?=MnPpV2FPT0WU
MMAC-SFNXLDfWdXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVHwfotjUUN3ME20MlI3QDV7IN88US=>NU\XVWFxW0GQR1XS
KYSE-70NXfr[II3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1W3TGlEPTB;ND6yPVM1KM7:TR?=NV;CWVNKW0GQR1XS
A204NF;NdXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGnpfZRKSzVyPUSuN|U5ODNizszNNXm5d2ZqW0GQR1XS
SCC-25NIflZ4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTRwM{W4NVkh|ryPM3LrXXNCVkeHUh?=
EPLC-272HMnm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml3ZTWM2OD12LkO4PVUh|ryPNVvwWFB7W0GQR1XS
CAL-120MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XTZmlEPTB;ND6zPFk6OiEQvF2=NFm3XHVUSU6JRWK=
LS-513NHTVbZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MljRTWM2OD12LkSyNVk5KM7:TR?=MVHTRW5ITVJ?
CAPAN-1M1m1[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFzrRYNKSzVyPUSuOFI{QDJizszNMV7TRW5ITVJ?
ESS-1NXXxOm9LT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVywRnUzUUN3ME20MlQzPzJ2IN88US=>Ml\GV2FPT0WU
GMS-10MoXuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXjnZmZlUUN3ME20MlQzQDF7IN88US=>NHPqfHFUSU6JRWK=
NCI-N87M2TmRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn\PTWM2OD12LkWwPFY5KM7:TR?=NEPOWopUSU6JRWK=
HMV-IIMoHKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4H6TGlEPTB;ND61NVc{KM7:TR?=NVW5SpdrW0GQR1XS
COLO-741MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWXJR|UxRTRwNUW5PVQh|ryPMlXYV2FPT0WU
MKN45MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUXJR|UxRTRwNUe3N|Ih|ryPNUHOV3NlW0GQR1XS
OAW-28NUnuOZQ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn;rTWM2OD12LkW4N|k5KM7:TR?=NWe5WVFKW0GQR1XS
OCI-AML2NX7Y[mtqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnPsTWM2OD12Lk[1NlM5KM7:TR?=MkPBV2FPT0WU
MDA-MB-231MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NULLWIJjUUN3ME20MlcxOjR|IN88US=>MWfTRW5ITVJ?
NCI-H1648MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIfEbGhKSzVyPUSuO|IzPzNizszNNH[yXoVUSU6JRWK=
NCI-H1792NXG2cHNIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3;jeWlEPTB;ND63OlExPyEQvF2=MY\TRW5ITVJ?
GCIYNFrnS5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTRwN{e0NlQh|ryPM3vpenNCVkeHUh?=
Hs-578-TMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUDnVWNjUUN3ME20Mlc4PjV3IN88US=>MVHTRW5ITVJ?
SW962Mo\US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4fKbmlEPTB;ND63PFAyOSEQvF2=MXHTRW5ITVJ?
NCI-H630M1WzW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFraWmdKSzVyPUSuO|gxQDFizszNM3zDe3NCVkeHUh?=
786-0NV;jTHg3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\3RlN2UUN3ME20Mlc5Pzd|IN88US=>MW\TRW5ITVJ?
FTC-133MlPtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7BPHNKSzVyPUSuO|kzPjNizszNM17Y[XNCVkeHUh?=
BT-20MnrDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XlVGlEPTB;ND63PVQzQSEQvF2=M3;2V3NCVkeHUh?=
MewoMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVvJR|UxRTRwOEG3OFch|ryPMmSxV2FPT0WU
SW780MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWDie4JbUUN3ME20Mlg2PzZ4IN88US=>NXXuOWhqW0GQR1XS
OE33MljBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTRwOEe3NVMh|ryPMnXhV2FPT0WU
HCC1569MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzxR45iUUN3ME20Mlg5PDV6IN88US=>M2jEb3NCVkeHUh?=
TE-6M2rVR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEfKRmxKSzVyPUSuPVM6PzdizszNMV\TRW5ITVJ?
SK-N-FIMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFOyXXhKSzVyPUSuPVQ1OjFizszNNWPZ[oRYW0GQR1XS
PANC-03-27NH7TenpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWfJR|UxRTRwOUm5OlIh|ryPNYWwbWh6W0GQR1XS
MCF7M{S5bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\1TmxiUUN3ME21MlAxPzN6IN88US=>M3LNbnNCVkeHUh?=
UACC-257MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV3h[FN1UUN3ME21MlAzQDR3IN88US=>MkXCV2FPT0WU
SW1088M1\tfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX\JR|UxRTVwMEK5OFQh|ryPMYDTRW5ITVJ?
A704M2m2SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV7RbVB[UUN3ME21MlA{ODZizszNMWHTRW5ITVJ?
A2058M3jOXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF3sT3JKSzVyPUWuNFU6ODhizszNM2H5bnNCVkeHUh?=
Calu-3NXHu[JpFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MY\JR|UxRTVwME[0OVIh|ryPMYnTRW5ITVJ?
RERF-LC-MSMnvPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2XzZ2lEPTB;NT6wOlkxOyEQvF2=MYfTRW5ITVJ?
AU565NHf0b3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXJR|UxRTVwMEm3NFIh|ryPMnrwV2FPT0WU
DMS-79NWnt[oRXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlrLTWM2OD13LkGzPFg{KM7:TR?=NIrwTItUSU6JRWK=
DK-MGMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIHUZYZKSzVyPUWuNVg1OzhizszNNEmwTmVUSU6JRWK=
HuCCT1NEHHPJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml7pTWM2OD13LkKzPFU3KM7:TR?=MYrTRW5ITVJ?
HT-144Ml7XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX\JR|UxRTVwMkS5PFch|ryPNFriflhUSU6JRWK=
M059JNXLlXoRGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{LDbmlEPTB;NT6yOVc3KM7:TR?=NGfMPZVUSU6JRWK=
COLO-792MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M33BWmlEPTB;NT6yOlM2PiEQvF2=MWPTRW5ITVJ?
SF539MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1LF[WlEPTB;NT6yOlY{OiEQvF2=M3W0[nNCVkeHUh?=
SK-UT-1NHfjdY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVjPRZB1UUN3ME21MlI4PzVzIN88US=>NI[1VY1USU6JRWK=
NCI-H1703MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIq1RnRKSzVyPUWuN|U5OjZizszNMYLTRW5ITVJ?
SW837NVewZ|lPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV\JR|UxRTVwM{e4O|gh|ryPM1PrdHNCVkeHUh?=
U251NWDxe5lzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFrob4xKSzVyPUWuN|kxQTZizszNMlHpV2FPT0WU
SW1710MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUTJR|UxRTVwNEG1OVQh|ryPM2fG[XNCVkeHUh?=
NCI-H1299NIPI[oZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYDoVJdLUUN3ME21MlQ3OzN3IN88US=>NXLhXGtEW0GQR1XS
RVH-421NXHCTZdET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTVwNEm5NFgh|ryPNXKydWRYW0GQR1XS
UM-UC-3MoPGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYjXcYd4UUN3ME21MlYzPjVzIN88US=>M3zq[nNCVkeHUh?=
MDA-MB-175-VIINF7qPYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoPLTWM2OD13Lk[0NFQyKM7:TR?=Mn3aV2FPT0WU
KYSE-270MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoH4TWM2OD13Lk[2NFMyKM7:TR?=Ml;vV2FPT0WU
COLO-668MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWf0XnpRUUN3ME21MlcyOzJizszNNYfWPINWW0GQR1XS
LN-405M4e5Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1y0cGlEPTB;NT63N|A5PSEQvF2=M3m1OnNCVkeHUh?=
HT-1376NHy1V3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MorWTWM2OD13Lke4NFUzKM7:TR?=MnzRV2FPT0WU
769-PMmq4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX33ToYyUUN3ME21Mlg3PzF6IN88US=>MY\TRW5ITVJ?
HuP-T3M1jvOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTVwOEi2O|ch|ryPNH3F[GRUSU6JRWK=
MDA-MB-415MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml7wTWM2OD13LkmyNVM6KM7:TR?=MmDOV2FPT0WU
MKN7MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELGSmZKSzVyPUWuPVg5KM7:TR?=MnP5V2FPT0WU
KS-1NEPBRXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml3ETWM2OD13Lkm4PFM3KM7:TR?=Mm\QV2FPT0WU
647-VNFHT[odIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIPPcXlKSzVyPUWuPVkyPDhizszNNUj5RZVmW0GQR1XS
COLO-679M3jFWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTZwMECyOVUh|ryPNEHuVI5USU6JRWK=
AN3-CANYXuUWU6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkC4TWM2OD14LkCzOFQyKM7:TR?=NHixZXRUSU6JRWK=
C32NIizdG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGHPc29KSzVyPU[uNVMxOzRizszNM1LG[XNCVkeHUh?=
KM12Mn\WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3nmN2lEPTB;Nj6yOFA6QSEQvF2=NUnhdFNjW0GQR1XS
KINGS-1NVPnbIJ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NE\5c5NKSzVyPU[uNlYyPTJizszNNWTsZ4VLW0GQR1XS
KYSE-410NEHTRoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3zE[WlEPTB;Nj6zNFY1PSEQvF2=NV3uPZV6W0GQR1XS
HPAF-IINITESIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2X1UmlEPTB;Nj6zOVQ5KM7:TR?=NFHNNmZUSU6JRWK=
LAN-6M{T5RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXPuZm45UUN3ME22MlQ6PjNzIN88US=>MX7TRW5ITVJ?
LU-99ANGHRZ2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVXJR|UxRTZwNUW5PFkh|ryPMVTTRW5ITVJ?
SJSA-1Mn7aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M32zSmlEPTB;Nj61OlM1PyEQvF2=NHr5SmZUSU6JRWK=
MSTO-211HMnztS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MW\JR|UxRTZwN{KyN|Mh|ryPMVjTRW5ITVJ?
SW900NYTKU|FQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkHmTWM2OD14Lke2NlIyKM7:TR?=NIPjbWlUSU6JRWK=
LNCaP-Clone-FGCMly1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1rrTGlEPTB;Nj64NFQxOyEQvF2=MlzEV2FPT0WU
OMC-1MnfaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXfNdFZ2UUN3ME22Mlg2PDB{IN88US=>MUTTRW5ITVJ?
IST-MEL1NW\tfY9HT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXnJSmJLUUN3ME22Mlg6PjZ7IN88US=>MlHCV2FPT0WU
TE-9M3[4dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUX4NoxxUUN3ME22Mlg6QDR5IN88US=>NFy4cGNUSU6JRWK=
NCI-H2030MoLYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFTtdm5KSzVyPU[uPVEzOjZizszNNFnhbItUSU6JRWK=
BFTC-909NYrzb3J6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XwUGlEPTB;Nz6wNFY1OSEQvF2=MoC4V2FPT0WU
NCI-SNU-5MlzFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmPnTWM2OD15LkCyNVU6KM7:TR?=NV7yfZdnW0GQR1XS
TE-5M1\iWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{T5O2lEPTB;Nz6wNlg5OSEQvF2=NYr1NJpPW0GQR1XS
SK-MES-1NFjxOlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2L3TWlEPTB;Nz6wOVQzPyEQvF2=NYToZnhLW0GQR1XS
SHP-77MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{fwdmlEPTB;Nz6xN|k2OiEQvF2=NVjxbnZHW0GQR1XS
NCI-H1623M3TJbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml[5TWM2OD15LkG0NFczKM7:TR?=M{TGXnNCVkeHUh?=
TE-11MkfwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2XjPWlEPTB;Nz6xOVE5PCEQvF2=NV2yVHUxW0GQR1XS
EKVXNH32NoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH\ROIFKSzVyPUeuNVkzPjdizszNMW\TRW5ITVJ?
OVCAR-3M17idmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV3JR|UxRTdwMkGxN|Mh|ryPM3TNUHNCVkeHUh?=
C3AMoLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUHJR|UxRTdwM{S1NkDPxE1?NV;pXFNKW0GQR1XS
CFPAC-1NXjTWppST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYXJR|UxRTdwM{[yNlIh|ryPNELIeGZUSU6JRWK=
MG-63M3m4Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml;PTWM2OD15LkSxPFQ6KM7:TR?=NH3aclZUSU6JRWK=
KYSE-140M2fBNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIDNUIdKSzVyPUeuOFQxPjFizszNM1vlZXNCVkeHUh?=
MPP-89NV\neodlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2\tdGlEPTB;Nz61PVczQSEQvF2=NUe2RVlQW0GQR1XS
COLO-824NFjXXlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTdwN{K4OlMh|ryPNWPnVYs6W0GQR1XS
SiHaMoLIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3nyRWlEPTB;Nz64N|cxPyEQvF2=NYjkdVlYW0GQR1XS
SNU-387NIryZ4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHr5T3hKSzVyPUeuPFU{PDdizszNMWrTRW5ITVJ?
A172MnnLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkD2TWM2OD15Lki2NVczKM7:TR?=M{PIRXNCVkeHUh?=
COLO-680NNVnXc25vT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIrWZo5KSzVyPUeuPVE4OyEQvF2=NEn4TppUSU6JRWK=
HCC1395NWPJd4FvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHS5U4dKSzVyPUiuNFU1PTJizszNMVzTRW5ITVJ?
NCI-H28MnTwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYPWWpRrUUN3ME24MlA2QTZ|IN88US=>MnHlV2FPT0WU
LC-2-adMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGW4[IFKSzVyPUiuNlE6OzdizszNNWXaeG16W0GQR1XS
S-117MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV7qeJpKUUN3ME24MlI2OzV|IN88US=>NGHEcopUSU6JRWK=
NCI-H1838NF\tS49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVfzcZY{UUN3ME24MlI2PzhzIN88US=>M2D5Z3NCVkeHUh?=
PANC-10-05MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWLJR|UxRThwM{ewOFch|ryPNVXrS3JyW0GQR1XS
KALS-1NWDSXVB3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LlTGlEPTB;OD61NFkzQCEQvF2=MYDTRW5ITVJ?
LS-1034M3rFPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRThwNUe0N|ch|ryPNYDOSllHW0GQR1XS
TGBC1TKBNG\yT2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnjqTWM2OD16LkezOVM2KM7:TR?=MUfTRW5ITVJ?
OE19NXS1T45ST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVTJR|UxRThwN{[yOlIh|ryPNX7ZO5Z4W0GQR1XS
D-502MGNH23fJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYrJR|UxRThwN{[5PVQh|ryPMV3TRW5ITVJ?
JEG-3NYrUbG5rT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVLJR|UxRThwN{i2NVgh|ryPNX[3eHRVW0GQR1XS
DBTRG-05MGMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHTQRmFKSzVyPUiuPFc2PjVizszNM3vUWHNCVkeHUh?=
ME-180NX\VZWNPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF;zOJJKSzVyPUmuNFY4OjVizszNNWTCOYNEW0GQR1XS
NCI-H1573M4T5Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1zBOGlEPTB;OT6xNFU{OiEQvF2=Mn62V2FPT0WU
HCC2998MkHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH36OYZKSzVyPUmuNVM3QDFizszNMkfQV2FPT0WU
ACHNNH;pTGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoDzTWM2OD17LkK0PVc2KM7:TR?=NUPuRo9iW0GQR1XS
D-392MGNGXOZ|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmDhTWM2OD17LkK1O|E2KM7:TR?=MYHTRW5ITVJ?
no-11M1j5Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnrJTWM2OD17LkK2NFI5KM7:TR?=NVjyWFUyW0GQR1XS
KLENFXJ[pJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmDPTWM2OD17LkOyNlMzKM7:TR?=NXv0Z3BnW0GQR1XS
Calu-6Mo\zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHu2WIhKSzVyPUmuN|c2OjhizszNM4m2cXNCVkeHUh?=
LB831-BLCM3:1UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX\JR|UxRTlwNEWxO|Eh|ryPNUXpbFl[W0GQR1XS
SW684M37lcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{PFNmlEPTB;OT60OlEyPiEQvF2=M1rrcHNCVkeHUh?=
SH-4NXv5eIhtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTlwNEmzOlQh|ryPM1zzUXNCVkeHUh?=
IST-MES1M173b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHPORXlKSzVyPUmuOVE3PDRizszNMnvOV2FPT0WU
Saos-2NXTpdGxmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWTVbG9sUUN3ME25MlUzOTl3IN88US=>NF;KU3RUSU6JRWK=
NCI-H2087NEHIbFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXLTWhKSzVyPUmuOlc{PTJizszNM3rQW3NCVkeHUh?=
SCC-9MnvpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkHvTWM2OD17LkexPFE3KM7:TR?=NI\mU3ZUSU6JRWK=
MFE-280M3LLSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnXhTWM2OD17LkeyO|g2KM7:TR?=M2LzbHNCVkeHUh?=
BENNFflTlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV:2emh[UUN3ME25MlgzOTV7IN88US=>MlvHV2FPT0WU
CP50-MEL-BMn;2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{HaSmlEPTB;OT65NlQ{OiEQvF2=MV;TRW5ITVJ?
SK-MEL-28Mnj1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M133fGlEPTB;MUCuNFE6OyEQvF2=NFTTbnJUSU6JRWK=
NCI-H2452M{fMRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlfaTWM2OD1zMD6xOkDPxE1?NGjtd4xUSU6JRWK=
NCI-H1395M33NNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlrGTWM2OD1zMD6xO|gh|ryPM1fWbnNCVkeHUh?=
NCI-H2052MmnjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHPT[FZKSzVyPUGwMlE5QDJizszNMVfTRW5ITVJ?
A375NHj1fplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{XlVGlEPTB;MUCuNlQ2OiEQvF2=MmrMV2FPT0WU
HCC38NYPZN5R3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3nFemlEPTB;MUCuN|IzKM7:TR?=MX;TRW5ITVJ?
LK-2M{f3SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYmyN3J1UUN3ME2xNE41OjB6IN88US=>Mn;KV2FPT0WU
SF126M3PuT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4r2fGlEPTB;MUCuOFczPyEQvF2=NYnUVnFTW0GQR1XS
SK-MEL-1M1\WN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkiyTWM2OD1zMD63PFM5KM7:TR?=NX6wcllqW0GQR1XS
ACNMmjqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkLRTWM2OD1zMD64Olc6KM7:TR?=NEGxSGVUSU6JRWK=
BB30-HNCMV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUPJR|UxRTFyLki3NVEh|ryPNVfpZ3FnW0GQR1XS
NCI-H747MmnoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2ewVWlEPTB;MUCuPFc1PiEQvF2=NVrGPHFpW0GQR1XS
KYSE-150Mk\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NInUZ45KSzVyPUGxMlA{QDdizszNMWrTRW5ITVJ?
D-247MGM33a[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUDJR|UxRTFzLkGwNFkh|ryPNXvXOWc2W0GQR1XS
BxPC-3MmjYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmeyTWM2OD1zMT6zO|Q4KM7:TR?=NV[3SWZYW0GQR1XS
SK-MEL-30NVPQPJI{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NW\wdmFMUUN3ME2xNU41ODd7IN88US=>NU[2THFLW0GQR1XS
CAS-1NVvhfplYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1;De2lEPTB;MUGuOFExQSEQvF2=M2iye3NCVkeHUh?=
no-10M2jpNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2fmRmlEPTB;MUKuNVIyPyEQvF2=NV;OcWVuW0GQR1XS
NCI-H2405NVzESHF[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUi1eG5TUUN3ME2xNk4zODN4IN88US=>NV\Tc4dyW0GQR1XS
KGNNX\GSY5iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWjJR|UxRTF{LkK5NFEh|ryPM1fnV3NCVkeHUh?=
BB49-HNCNUDTRpUzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4PBSmlEPTB;MUKuN|k2PiEQvF2=M{TqSnNCVkeHUh?=
NCI-H1693MmO5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlrETWM2OD1zMj61PFE3KM7:TR?=M{XkcXNCVkeHUh?=
RO82-W-1MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWjJR|UxRTF|LkC2OFkh|ryPNIXHSodUSU6JRWK=
CAL-85-1MnfaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3jTNmlEPTB;MUOuOFM6QSEQvF2=Mn2xV2FPT0WU
H-EMC-SSNGW2U3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn;uTWM2OD1zMz65NVA1KM7:TR?=MnrNV2FPT0WU
SW1783MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYrFV|V6UUN3ME2xOE4zOzlzIN88US=>M2n2NHNCVkeHUh?=
LB771-HNCNEnO[W5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYDJR|UxRTF2LkSxPUDPxE1?MkL6V2FPT0WU
HCC70MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mly4TWM2OD1zND60NlM{KM7:TR?=MV3TRW5ITVJ?
KNS-81-FDMkPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFPBc2lKSzVyPUG0MlcxPDVizszNNUDh[mFpW0GQR1XS
KYSE-520MojnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGnNe5FKSzVyPUG0MlkzPyEQvF2=MoDWV2FPT0WU
TGBC24TKBMWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NULXeGhbUUN3ME2xOE46PTN7IN88US=>MUnTRW5ITVJ?
SNB75M4TLRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NULDUJBkUUN3ME2xOU4xPzJ7IN88US=>M3zlNXNCVkeHUh?=
SW872MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2rPfWlEPTB;MUWuNlIyQCEQvF2=MVXTRW5ITVJ?
U031M{nxSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTF3LkiwNlgh|ryPMWjTRW5ITVJ?
ChaGo-K-1Ml;YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTF3LkizOVkh|ryPNFrYbm9USU6JRWK=
NCI-H441NELKXpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWHJR|UxRTF4LkCwN|kh|ryPM4rlUHNCVkeHUh?=
TE-12MkXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MljvTWM2OD1zNj6xPFc{KM7:TR?=M3v4bXNCVkeHUh?=
NCI-H1755M{TPdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmHZTWM2OD1zNj61O|Mh|ryPM4nWNHNCVkeHUh?=
KNS-42M1Xwe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHn5c4FKSzVyPUG2MlY2QDlizszNNFPuO4hUSU6JRWK=
SK-PN-DWMkPjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlPuTWM2OD1zNz60NlAyKM7:TR?=M3K1cnNCVkeHUh?=
NCI-H226NVHMNnV2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVjLU2ZQUUN3ME2xO{46OzR3IN88US=>NGXaZoJUSU6JRWK=
K-562MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2i5fmlEPTB;MUiuOlMyPyEQvF2=MXHTRW5ITVJ?
A388M3;lSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml;zTWM2OD1zOT6wN|A{KM7:TR?=NYCzUZhlW0GQR1XS
ZR-75-30NELOWXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGfRU4FKSzVyPUG5MlA6PjhizszNNXrkTHN7W0GQR1XS
LU-135M{fOVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoDsTWM2OD1zOT6yOlM3KM7:TR?=NHLQc45USU6JRWK=
NCI-H2029MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHWwfJNKSzVyPUG5MlYxOjFizszNMWnTRW5ITVJ?
HT-1197NUXCW2NQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2r6ZWlEPTB;MUmuPVIzPyEQvF2=NY[xOGlKW0GQR1XS
IGR-1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4X3[mlEPTB;MkCuN|EyPyEQvF2=M3qwR3NCVkeHUh?=
U-87-MGNX3NPXZoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4HjXGlEPTB;MkCuOlQyOyEQvF2=MX\TRW5ITVJ?
NCI-H1304NEPlRXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWr0[odHUUN3ME2yNE44PTBzIN88US=>MmjrV2FPT0WU
RCC10RGBMmCyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHtTXBKSzVyPUKxMlI5OjlizszNM3qxNXNCVkeHUh?=
NCI-H520Ml;RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rGWGlEPTB;MkKuO|YyOSEQvF2=NIf0[3VUSU6JRWK=
SK-LU-1M4roN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlXhTWM2OD1{Mz6wO|E5KM7:TR?=NEfabXJUSU6JRWK=
UACC-893Mn3vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHURpBKSzVyPUKzMlExOzhizszNMm[wV2FPT0WU
NCI-H2347MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlLITWM2OD1{Mz6yOlc1KM7:TR?=NH;kTZNUSU6JRWK=
U-118-MGMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUL3O293UUN3ME2yN{44OjF5IN88US=>MXXTRW5ITVJ?
NCI-H596NXT3W2VDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NI\sNWhKSzVyPUKzMlkxPTVizszNMYfTRW5ITVJ?
MZ1-PCMVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHLONnZKSzVyPUK0MlY4PTlizszNNUjYVIh6W0GQR1XS
SW1417M2rjWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4\sd2lEPTB;MkWuNlQ6QCEQvF2=MX3TRW5ITVJ?
NCI-H82NYLjTGhWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTJ4LkSyPFgh|ryPNGTjW|dUSU6JRWK=
COLO-678M3L4dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV7JR|UxRTJ5LkS5NVkh|ryPM3PjS3NCVkeHUh?=
KURAMOCHIMl30S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2LFcmlEPTB;MkiuNVI3KM7:TR?=NFv6XJFUSU6JRWK=
NCI-H1650MnTIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlSyTWM2OD1|MD6xPVI1KM7:TR?=NF76TVFUSU6JRWK=
HCC1954Mn;OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRTNzLkO2OlYh|ryPM3\ydXNCVkeHUh?=
GAKNHvIUYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MonHTWM2OD1|Mj6yOlE3KM7:TR?=Moj6V2FPT0WU
YAPCMoLNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFrxZYVKSzVyPUOzMlc3PDhizszNMoLiV2FPT0WU
NCI-H2228MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlvYTWM2OD1|ND6zOlA2KM7:TR?=M1juXXNCVkeHUh?=
VMRC-RCZM3fBW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4rYdmlEPTB;M{[uN|AzOiEQvF2=NVHveWZUW0GQR1XS
NMC-G1MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIj4cVFKSzVyPUO3MlA2OjlizszNNFTsVnNUSU6JRWK=
D-336MGNXTQV3B6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MljLTWM2OD12MT64OFQzKM7:TR?=NYjDVIpmW0GQR1XS
UACC-62Ml\MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUDJR|UxRTR{LkW1NFUh|ryPM{XIOHNCVkeHUh?=
C-33-ANYnWbGJ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFmxUXZKSzVyPUS1MlMzPTZizszNNFXqOWhUSU6JRWK=
HCC1937M1\QNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVHJR|UxRTR5LkG5OVgh|ryPM2[y[nNCVkeHUh?=
HDLM-2MmPYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXi2VWVMUUN3ME20O{4zOjh5IN88US=>MX3TRW5ITVJ?
NCI-H727MlP1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFHhUGFKSzVyPUS3MlI1PTFizszNNYW4TJloW0GQR1XS
NYM4W2NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFjBNnJKSzVyPUS5MlM6ODhizszNM{PRUXNCVkeHUh?=
NCI-H2291MmHqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnT0TWM2OD12OT64N|AyKM7:TR?=NUPNXFU3W0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo Administration of Vorinostat (~100 mg/kg/day) significantly inhibits the growth of CWR22 human prostate xenografts in nude mice with tumor reductions of 78%, 97% and 97%, at doses of 25 mg/kg/day, 50 mg/kg/day and 100 mg/kg/day, respectively, compared with control. Vorinostat induces the accumulation of acetylated core histones and prostate-specific antigen mRNA expression in CWR22 cells, resulting in higher levels of serum prostate-specific antigen than predicted from tumor volume alone. [2] Oral administration of Vorinostat (0.67g/L) crosses the blood-brain barrier, increases histone acetylation in the brain, and dramatically improves the motor impairment in the R6/2 mice model of Huntington's disease. [5]
Features

Protocol(Only for Reference)

Kinase Assay:

[1]

Immunoprecipitation-HDAC assays The lysate of Jurkat cells is incubated for 1 hour on ice and cleared by centrifugation at 12,000 g for 10 minutes at 4 °C. Supernatants are precleared with 30 μL of 50% protein G-Sepharose slurry for 1 hour at 4 °C. Beads are pelleted by centrifugation and supernatants are incubated for 1 hour at 4 °C with 10 μg of IgG fraction from anti-HDAC1 or HDAC3 polyclonal antisera (preincubated 2 hours at room temperature with either the homologous or heterologous immunizing peptide). Both antisera are raised in rabbits against the carboxylterminal peptide of HDAC1 and HDAC3 by using synthetic peptides coupled to keyhole limpet hemocyanin. 30 μL of 50% protein G-Sepharose slurry is added for 1 hour at 4 °C. Immune complexes are pelleted by centrifugation and washed three times with 1 mL of lysis buffer. Beads are resuspended in 200 μL of HDAC buffer (20 mM Tris-HCl, pH 8.0/150 mM NaCl/10% glycerol), and the HDAC assay is performed with an 3H-acetylated peptide corresponding to amino acids 1-24 of histone H4. Released [3H]acetic acid is quantified by scintillation counting. For inhibitions studies, the immunoprecipitated complexes are preincubated with the different concentrations of Vorinostat for 30 minutes at 4 °C.

Cell Assay:

[2]

Cell lines LNCaP, PC-3, and TSU-Pr1
Concentrations Dissolved in DMSO, final concentrations ~7.5 μM
Incubation Time 1, 2, 3 and 4 days
Method

Cells are exposed to various concentrations of Vorinostat for 1, 2, 3 and 4 days. Cell viability is assessed by trypan blue dye exclusion.

Animal Study:

[2]

Animal Models Male BALB/c nude (nu/nu) mice implanted with CWR22 tumor cells
Formulation Dissolved in DMSO
Dosages ~100 mg/kg/day
Administration Injection i.p.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Richon VM, et al. Proc Natl Acad Sci U S A, 1998, 95(6), 3003-3007.

[2] Butler LM, et al. Cancer Res, 2000, 60(18), 5165-5170.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-23)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT02589145 Recruiting Lymphoma M.D. Anderson Cancer Center|Celgene Corporation June 2016 Phase 1|Phase 2
NCT02707900 Not yet recruiting HIV-1 Infection Cynthia L Gay, MD|National Institute of Allergy and Infec  ...more Cynthia L Gay, MD|National Institute of Allergy and Infectious Diseases (NIAID)|University of North Carolina, Chapel Hill March 2016 Phase 1
NCT02638090 Recruiting Lung Cancer|Non-small Cell Lung Cancer H. Lee Moffitt Cancer Center and Research Institute|Merck  ...more H. Lee Moffitt Cancer Center and Research Institute|Merck Sharp & Dohme Corp. February 2016 Phase 1|Phase 2
NCT02619253 Recruiting Renal Cell Carcinoma|Urinary Bladder Neoplasms Roberto Pili|Indiana University January 2016 Phase 1|Phase 2
NCT02336074 Recruiting HIV Imperial College London|Medical Research Council|Universi  ...more Imperial College London|Medical Research Council|University of Oxford|University of Cambridge|Chelsea and Westminster NHS Foundation Trust|Royal Free Hospital NHS Foundation Trust|Brighton and Sussex University Hospitals NHS Trust|Guys and St Thomas NHS Foundation Trust|Central and North West London NHS Foundation Trust November 2015 Phase 2

view more

Chemical Information

Download Vorinostat (SAHA, MK0683) SDF
Molecular Weight (MW) 264.3
Formula

C14H20N2O3

CAS No. 149647-78-9
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 53 mg/mL (200.52 mM)
Ethanol 3 mg/mL (11.35 mM)
Water <1 mg/mL (<1 mM)
In vivo 2% DMSO+30% PEG 300+ddH2O 5mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name N1-​hydroxy-​N8-​phenyl-octanediamide

Customer Product Validation(20)


Click to enlarge
Rating
Source Nat Biotechnol 2011 29, 255-265. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Immunofluorescence analysis
Cell Lines K562 cells
Concentrations 5 µM
Incubation Time 6 h
Results SAHA and other nonselective HDAC inhibitors increased steady-state acetylation of tubulin and histones manifested by the staining of acetylated microtubules and punctuate nuclear staining of acetylated histone.

Click to enlarge
Rating
Source Nature 2011 471, 235-9. Vorinostat (SAHA, MK0683) purchased from Selleck
Method MTT cell viability assay
Cell Lines T-ALL cell lines
Concentrations 0.01-100 uM
Incubation Time 72 h
Results It examined responsiveness to dexamethasone and the class I/II HDAC inhibitor vorinostat in a panel of T-ALL cell lines with wild type or mutant CREBBP alleles. This demonstrated sensitivity to vorinostat at clinically useful concentrations (IC50 below 1礛) in the majority of cell lines tested.

Click to enlarge
Rating
Source J Exp Med 2012 209, 35-50. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Western blot
Cell Lines BM cells
Concentrations 100 ug/g
Incubation Time 11 days
Results Because of the observed decrease in global histone H3 acetylation, It treated NF-E2 tg mice with the HDAC-I vorinostat (SAHA) to restore physiological levels of histone H3 acetylation. Vorinostat treatment significantly increased H3 acetylation in NF-E2 tg animals.

Click to enlarge
Rating
Source Clin Cancer Res 2012 18, 3822-33. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Western blotting
Cell Lines LNCaP/22Rv1 cells
Concentrations 0.5/1μM
Incubation Time 24 h
Results The apoptosis induced by 0.5μM or 1μM SAHA was significantly increased in cells co-treated with 10μM bicalutamide; this was paralleled by demonstrable knockdown of c-FLIPL and c-FLIPS expression in these cells and by an enhanced level of cleaved PARP protein (Figure A/B). At the highest concentration of SAHA, co-treatment induced a rise of caspase-8 and caspase-3/7 activity to 245.3±28.9% and 265.5±15.6%, respectively (Figure C, left panel). Similarly, in LNCaP cells, caspase activity was augmented in response to SAHA and SAHA/bicalutamide; where there was a > 3-fold increase in caspase 3/7 activity with 2μM SAHA in combination with bicalutamide (Figure C, right panel). To confirm the importance of caspase-8 in initiating drug-induced apoptosis, caspase-8 activity was inhibited by the addition of Z-IETD-fmk prior to the drug treatments (Figure D).

Click to enlarge
Rating
Source Diabetologia 2012 55, 2421-2431. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Analyses of efficacy, potency and IC50
Cell Lines INS-1 cells
Concentrations
Incubation Time
Results HC toxin, CI-994, PCI24781 and LAQ824 all protected against cytokine-induced beta cell death, whereas the HDAC8-selective inhibitor PCI34051 showed no protection.

Click to enlarge
Rating
Source Mol Carcinog 2012 52, 459-74. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Real-Time Cell Growth Analysis
Cell Lines HT29/HCT116 cells
Concentrations 1-3 μM
Incubation Time 48 h
Results Treatment of HT29 and HCT116 CRC cells with increasing concentrations of butyrate or SAHA led to decreased proliferation over a 48 h period.

Click to enlarge
Rating
Source J Neurochem 2012 123 Suppl 2, 108-15. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Confocal microscopy/pixel-intensity measurements
Cell Lines mouse optic nerves
Concentrations 5 μM
Incubation Time
Results Suberoylanilide hydroxyamic acid (SAHA) preserves CFP (+) expression in mouse optic nerves (MONs) from older mice.

Click to enlarge
Rating
Source J Transl Med 2011 9, 37. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Tumor xenograft studies
Cell Lines female athymic nude mice
Concentrations 25 mg/kg
Incubation Time two weeks
Results SAHA , it self showed some anti-cancer effect in two tumor models ( Figure D and E). However, when mice were treated with S AHA followed by IL-13-PE, a significant decrease in tumor size was observed. In addition, 50% of mice showed complete elimination of their tumors in combination group. Next, we e valuated anti-cancer effect of combination of SAHA and IL-13-PE in IL-13Ra 2-positive pancreatic cancer model (HS766T and M IA -PaCa2). We observed that IL-13 - PE could significantly decrease tumor size in both IL-13Ra 2- positive tumors (Figure F and G). But when combined with SAHA , IL-13-PE not only decreased tumor size but also completely eliminated tumors in 66 to 83% of mice. These data suggest that SAHA can enhance anti-cancer effect of IL-13-PE even in IL-13Ra 2-positive pancreatic cancers.

Click to enlarge
Rating
Source J Transl Med 2011 9, 37. Vorinostat (SAHA, MK0683) purchased from Selleck
Method qRT-PCR/immunostaining
Cell Lines female athymic nude mice
Concentrations 25 mg/kg
Incubation Time two weeks
Results Human IL-13Rα2 mRNA was significantly increased in tumors in both SAHA treated mice (Figure A). IL-13-PE treatment had no effect by itself but in combination with SAHA , a significant decrease in IL-13Rα2 expression was observed. In contrast, none of the organs except brain showed a modest increase in mouse IL-13Rα2 mRNA expression (Figure B). We also examined IL-13Rα2 protein expression by IHC. Similar to mRNA results, human IL-13Rα2 was dramatically increased in tumors from SAHA treated mice and when combined with IL-13 - PE, a decrease in IL-13Rα2 expression was observed ( Figure C ) . In normal tissues, mouse IL-13Rα2 was not detected or levels were below the detection limit of the assay in all organs examined (Figure D).

Click to enlarge
Rating
Source Exp Dermatol 2010 19, 1096-1102. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Tumor volume measurement
Cell Lines MyLa2059 cells
Concentrations 60 mg/kg
Incubation Time
Results The tumor growth was suppressed in mice treated with vorinostat when compared to mice treated with vehicle.

Click to enlarge
Rating
Source Invest New Drugs 2012 30, 541-547. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Western blot
Cell Lines BT-474 cells
Concentrations 0-10 μM
Incubation Time 8 h
Results Proteolytic processing of the caspase substrate PARP, a hall mark of apoptosis, increased in the BT-474 cells treated with SAHA and TRAIL.These results demonstrate that the combined treatment with SAHA and TRAIL induces significant apoptosis in these breast cancer cell lines.The activation of caspase-8 induced by TRAIL was clearly enhanced by pre-treatment with SAHA.The amount of intact Bid clearly diminished in the cells treated with both SAHA and TRAIL when compared to the cells treated with TRAIL or SAHA alone(Fig.a).The cellular levels of both cFLIPL and cFLIPS protein decreased in a dose-depen dent manner following exposure to SAHA, where as the levels of other prote ins in the TRAIL signalling pathway were not affected by SAHA (Fig.b)

Click to enlarge
Rating
Source Invest New Drugs 2012 30, 541-547. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Analysis of apoptosis
Cell Lines BT-474 cells, MDA-MB-231 cells
Concentrations 0-10 µM
Incubation Time 8 h
Results When the cells were exposed to SAHA for 8 h prior to the overni ght addition of TRAIL , apoptotic cell death was increased signifi cantly in both cell lines, particularly in the highly resistant BT-474 cells that over-expre s the ErbB2 /Her-2/ neu oncogene.

Click to enlarge
Rating
Source Invest New Drugs 2012 30, 541-547. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Western blot
Cell Lines BT-474 cells
Concentrations 5 µM
Incubation Time 8 h
Results Both MG132 and epoxomycin blocked the down-regulation of the two cFLIP isoforms induced by SAHA in BT-474 cells (Fig. a).even though siRNA treatment effectively depleted Itch/AIP4 in SAHA-treated cells, its depletion did not influence the down-regulation of cFLIP proteins (Fig. b).

Click to enlarge
Rating
Source Invest New Drugs 2012 30, 541-547. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Analysis of apoptosis, Western blot
Cell Lines BT-474 cells
Concentrations 0-10 μM
Incubation Time 8 h
Results Cells over-expressing cFLIPL were clearly more resistant to SAHA-induced sensitization to TRAIL-mediated apoptosis than cells expressing normal cFLIP levels (Fig. b)

Click to enlarge
Rating
Source BMC Neurosci 2011 12, 50. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Flow cytometry/Western blot
Cell Lines NSCs
Concentrations 1 μM
Incubation Time 48 h
Results Western blot analysis of whole cell extracts from adult NSCs treated with HDACi for 48 hours confirms SAHA and NaB treatment results in an increase inhistone3 (H3)acetylation levels when compared to DMSO and water vehicle controls (Figure a). Qu antita-tive an alysis of adult NSCs after 7-days HDACi treatment confirms SAHA and NaB treatment dramatically inhibits the formation of neurospheres (diameter≥ 50 μm) and increase the prevalence of small (≥ 4 cells,diameter < 50 μm) cell clusters in culture (Figure c ). flow cytometry reveals SAHA and NaB exposureresults in a 10 % reduction in cell viability compared to vehicle controls after 48 hours treatment (Figure d).

Click to enlarge
Rating
Source BMC Neurosci 2011 12, 50. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Flow cytometry/Fluorescence micrographs
Cell Lines NSCs
Concentrations 1 μM
Incubation Time 16 h
Results The addition of either SAHA or NaB significantly inhibited DNA synthesis in adult mouse NSCsin vitro. these flow cytometry data indicate that the suppression of NSC proliferation by SAHA and NaB result s in a G1-to-S phase block in cell cycle progression.

Click to enlarge
Rating
Source BMC Neurosci 2011 12, 50. Vorinostat (SAHA, MK0683) purchased from Selleck
Method immunofluorescence cell fate assay/Western blot
Cell Lines NSCs
Concentrations 1 μM
Incubation Time 48 h
Results SAHA significantly reduced glial (p < 0.001) and oligodendrocyte (p < 0.05) differentiated cell fate in culture w hen compared to DMSO vehicle controls (Figure a). Fold-changes of b-catenin nuclear protein levels normalized to laminin A/C reveal marginal opposing +/- effects of SAHA (-1.49 ± 0 .11) and NaB (1.36 ± 0.33) treatment, indicating SAHA modulates cell fate via mechanisms independent of increased β-catenin stabilization.

Click to enlarge
Rating
Source Pediatr Surg Int 2012 28, 579-89. Vorinostat (SAHA, MK0683) purchased from Selleck
Method DAPI staining and microscopy/ Western blot
Cell Lines HUH6 cells/ HepT1 cells
Concentrations 0.2/0.5 μM
Incubation Time 72 h
Results The effect of VX-680 and/or SAHA on cell morphology was similar in both, HepT1 and HUH6 cells (Fig. b). There was also a significant increase in both the nuclei and cell diameter in HepT1 cells when treated with VX–680 alone or in combination. In both HB cell. As shown in Fig. c, In both HB cell lines treatment with VX–680 and the combination with SAHA led to a decrease in histone H3 phosphorylation.

Click to enlarge
Rating
Source Dr. Akihiko Yoshimura of Akihiko Yoshimura. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Hoechst staining
Cell Lines C2C12 cells
Concentrations
Incubation Time
Results

Click to enlarge
Rating
Source Dr. Zhang of Tianjin Medical University. Vorinostat (SAHA, MK0683) purchased from Selleck
Method Western blot
Cell Lines MDB-MA-231 cells
Concentrations 0-20 μM
Incubation Time
Results

Frequently Asked Questions

  • Question 1
    What’s the recommendation about reconstitution of the compound for in vivo animal study?

    Answer: We recommend the following vehicle for S1047: 2% DMSO, 40% PEG 300, 5% Propylene glycol, 1% Tween 80 at 5 mg/mL.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related HDAC Products

  • LMK-235

    LMK-235 is a selective inhibitor of HDAC4 and HDAC5 with IC50 of 11.9 nM and 4.2 nM, respectively.

  • CAY10603

    CAY10603 is a potent and selective HDAC6 inhibitor with IC50 of 2 pM, >200-fold selectivity over other HDACs.

  • 4SC-202

    4SC-202 is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively. Also displays inhibitory activity against Lysine specific demethylase 1 (LSD1). Phase 1.

  • Panobinostat (LBH589)

    Panobinostat (LBH589) is a novel broad-spectrum HDAC inhibitor with IC50 of 5 nM in a cell-free assay. Phase 3.

  • Entinostat (MS-275)

    Entinostat (MS-275) strongly inhibits HDAC1 and HDAC3 with IC50 of 0.51 μM and 1.7 μM in cell-free assays, compared with HDACs 4, 6, 8, and 10. Phase 3.

  • Trichostatin A (TSA)

    Trichostatin A (TSA) is an HDAC inhibitor with IC50 of ~1.8 nM in cell-free assays.

  • Romidepsin (FK228, Depsipeptide)

    Romidepsin (FK228, depsipeptide) is a potent HDAC1 and HDAC2 inhibitor with IC50 of 36 nM and 47 nM in cell-free assays, respectively.

    Features:More effective than other classical HDAC inhibitors such as TSA, TPX, and butyrate.

  • RGFP966

    RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.

  • Tubastatin A

    Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective against all the other isozymes (1000-fold) except HDAC8 (57-fold).

  • Mocetinostat (MGCD0103)

    Mocetinostat (MGCD0103) is a potent HDAC inhibitor with most potency for HDAC1 with IC50 of 0.15 μM in a cell-free assay, 2- to 10- fold selectivity against HDAC2, 3, and 11, and no activity to HDAC4, 5, 6, 7, and 8. Phase 2.

Recently Viewed Items

Tags: buy Vorinostat (SAHA, MK0683) | Vorinostat (SAHA, MK0683) ic50 | Vorinostat (SAHA, MK0683) price | Vorinostat (SAHA, MK0683) cost | Vorinostat (SAHA, MK0683) solubility dmso | Vorinostat (SAHA, MK0683) purchase | Vorinostat (SAHA, MK0683) manufacturer | Vorinostat (SAHA, MK0683) research buy | Vorinostat (SAHA, MK0683) order | Vorinostat (SAHA, MK0683) mouse | Vorinostat (SAHA, MK0683) chemical structure | Vorinostat (SAHA, MK0683) mw | Vorinostat (SAHA, MK0683) molecular weight | Vorinostat (SAHA, MK0683) datasheet | Vorinostat (SAHA, MK0683) supplier | Vorinostat (SAHA, MK0683) in vitro | Vorinostat (SAHA, MK0683) cell line | Vorinostat (SAHA, MK0683) concentration | Vorinostat (SAHA, MK0683) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us